data_1bv2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bv2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 HD11 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.425 ' H ' HG23 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 80' ' ' THR . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' HD11 ' A' ' 69' ' ' ILE . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.457 ' CB ' ' HZ1' ' A' ' 72' ' ' LYS . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.506 HD13 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' CB ' ' A' ' 68' ' ' SER . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 15' ' ' THR . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.451 ' N ' HD13 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp . . . . . 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 tp . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HB2' HH11 ' A' ' 18' ' ' ARG . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' CD ' ' H ' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.476 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.5 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 HH12 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.44 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 54' ' ' ALA . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 HD11 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.414 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 2' ' ' THR . 63.2 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.495 HD11 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 71.6 m-80 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.501 HD11 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.433 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.425 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.425 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG2' ' H ' ' A' ' 71' ' ' SER . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 HD11 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -18.66 78.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -94.26 37.68 1.1 Allowed 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.472 1.13 . . . . 0.0 109.406 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.4 m 28.7 -126.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 112.79 -2.004 . . . . 0.0 113.786 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.8 p 44.45 26.77 0.19 Allowed 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 123.692 1.71 . . . . 0.0 111.051 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -135.67 4.45 3.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 110.62 -2.991 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.59 113.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 114.263 -2.78 . . . . 0.0 103.729 179.862 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.485 ' N ' HD13 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.425 ' H ' HG23 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp -101.76 155.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -117.67 152.46 35.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 123.733 0.646 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.8 m -140.3 166.56 24.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.631 1.207 . . . . 0.0 109.922 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m 93.4 -54.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -94.43 59.89 2.59 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.71 -43.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.824 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.496 1.851 0 C-N-CA 129.12 2.968 . . . . 0.0 106.128 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' SG ' HG23 ' A' ' 90' ' ' VAL . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' ND2' ' SG ' ' A' ' 87' ' ' CYS . 31.7 m-80 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 80' ' ' THR . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 119.59 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -114.58 161.03 18.6 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' SG ' ' ND2' ' A' ' 49' ' ' ASN . 8.1 m -112.89 -178.42 3.38 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.876 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 m 122.99 -42.39 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -99.19 44.16 1.03 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.493 HG23 ' SG ' ' A' ' 48' ' ' CYS . 57.5 t -122.0 56.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.8 t . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 110.526 -3.034 . . . . 0.0 107.609 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.427 ' SG ' HD11 ' A' ' 69' ' ' ILE . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.429 ' NH1' ' HA ' ' A' ' 91' ' ' SER . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HE ' ' HA ' ' A' ' 89' ' ' ARG . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' H ' HG23 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.98 165.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 87' ' ' CYS . 38.7 t70 -123.85 162.93 22.27 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.722 0.638 . . . . 0.0 110.349 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 86' ' ' ASP . 29.0 m -152.91 108.98 3.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 125.02 1.45 . . . . 0.0 107.089 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.5 p -148.8 84.22 1.47 Allowed 'General case' 0 C--N 1.296 -1.726 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 91' ' ' SER . 2.6 ptm180 43.37 73.97 0.13 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.398 1.571 . . . . 0.0 107.109 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.73 40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.35 -3.114 . . . . 0.0 109.662 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 89' ' ' ARG . 19.6 m . . . . . 0 C--N 1.306 -1.311 0 CA-C-N 112.561 -2.109 . . . . 0.0 107.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.443 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.6 tp -105.8 151.56 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.37 148.7 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.932 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 88' ' ' SER . 33.4 m -129.99 157.02 43.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 39.5 t 114.55 -37.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.29 -3.226 . . . . 0.0 102.29 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -93.59 47.05 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.28 -59.91 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 112.908 -1.951 . . . . 0.0 107.786 179.639 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.457 ' CB ' ' HZ1' ' A' ' 72' ' ' LYS . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.506 HD13 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.457 ' HZ1' ' CB ' ' A' ' 68' ' ' SER . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.429 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.73 171.64 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -130.72 -80.39 0.54 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 88' ' ' SER . 98.6 m 75.58 174.59 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.156 2.16 . . . . 0.0 108.704 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 7.3 t 144.26 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -117.21 59.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.93 -31.45 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 111.201 -2.727 . . . . 0.0 113.357 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 116.115 -1.897 . . . . 0.0 115.475 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD13 ' N ' ' A' ' 15' ' ' THR . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.451 ' N ' HD13 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.464 ' SG ' HD11 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.409 ' CG2' ' H ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp -1.25 83.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -100.22 140.03 35.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.86 -173.01 2.22 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.388 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m 124.69 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 127.263 2.225 . . . . 0.0 108.09 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 52.16 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG23 ' SG ' ' A' ' 48' ' ' CYS . 61.0 t -121.67 73.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 112.203 -2.272 . . . . 0.0 107.924 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.835 -1.555 . . . . 0.0 111.543 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' CD ' ' HA ' ' A' ' 91' ' ' SER . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.38 166.86 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -114.58 102.4 10.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.137 0.898 . . . . 0.0 111.704 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 15.5 m -110.73 66.13 0.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.0 t -137.21 73.85 1.46 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.76 75.97 0.37 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -83.22 -33.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 112.414 -2.175 . . . . 0.0 112.563 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . 34.9 t . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.422 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.492 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.411 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.0 tp -8.05 107.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.78 154.47 21.48 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 49' ' ' ASN . 10.6 m -105.07 61.71 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 125.631 2.634 . . . . 0.0 111.774 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.4 p -121.13 -13.05 8.6 Favored 'General case' 0 C--N 1.289 -2.036 1 CA-C-N 108.208 -4.087 . . . . 0.0 110.285 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.79 45.09 2.32 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 101.818 -3.401 . . . . 0.0 101.818 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.492 ' CG1' ' HG2' ' A' ' 44' ' ' ARG . 59.5 t -126.69 85.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.152 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.372 -1.299 . . . . 0.0 107.757 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HB2' HH11 ' A' ' 18' ' ' ARG . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' CD ' ' H ' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.476 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.484 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp 3.14 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -93.98 63.99 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.578 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 m -30.64 128.27 0.14 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.923 -1.944 . . . . 0.0 113.2 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -172.92 -42.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.757 2.536 . . . . 0.0 108.009 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -122.66 75.47 1.27 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 111.998 -2.364 . . . . 0.0 108.831 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.9 t -106.94 -37.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 112.424 -2.171 . . . . 0.0 105.813 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.447 -1.263 . . . . 0.0 108.971 179.721 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.5 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 HH12 HG21 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.44 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.407 ' CZ ' ' HA ' ' A' ' 91' ' ' SER . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 54' ' ' ALA . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 HD11 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG21 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.46 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.9 159.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.9 168.49 11.42 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.03 0.919 . . . . 0.0 111.662 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' SER . 63.7 m -145.69 163.98 33.22 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.349 -2.205 . . . . 0.0 106.674 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 41.2 t 108.45 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -95.28 37.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.74 55.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 122.407 1.099 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.407 ' HA ' ' CZ ' ' A' ' 45' ' ' ARG . 32.7 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 116.77 -1.586 . . . . 0.0 110.427 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.414 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 2' ' ' THR . 63.2 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.457 HH12 ' CB ' ' A' ' 91' ' ' SER . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.495 HD11 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp -25.42 137.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.79 132.98 53.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.617 0.722 . . . . 0.0 110.728 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.5 m -131.21 171.42 13.33 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.251 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.5 p 123.68 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -125.29 69.45 1.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 91' ' ' SER . 5.3 p -88.33 -31.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.973 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.457 ' CB ' HH12 ' A' ' 44' ' ' ARG . 11.5 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 114.985 -2.436 . . . . 0.0 106.702 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 71.6 m-80 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.501 HD11 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.433 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp -120.89 143.0 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -126.4 67.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 88' ' ' SER . 35.5 m -44.02 144.12 0.99 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 34.4 t 128.37 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.09 50.27 1.63 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.46 60.58 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 112.384 -2.189 . . . . 0.0 108.945 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.425 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG2' ' H ' ' A' ' 71' ' ' SER . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.494 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -116.52 157.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 55.0 t0 -127.09 -48.75 1.46 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 86' ' ' ASP . 77.0 m 120.56 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 100.526 -3.879 . . . . 0.0 100.526 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -147.04 78.19 1.48 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.483 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 56.55 64.84 1.56 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.519 1.152 . . . . 0.0 108.033 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 t -89.44 64.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.933 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' LYS . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.421 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD3' ' CG ' ' A' ' 72' ' ' LYS . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HD3' ' A' ' 23' ' ' PRO . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.508 ' H ' HG22 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 41' ' ' THR . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 81' ' ' ILE . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 79' ' ' TYR . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 HH21 ' A' ' 45' ' ' ARG . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.414 HH21 HG22 ' A' ' 41' ' ' THR . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 9.6 tp . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' SER . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ALA . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp . . . . . 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 65' ' ' ASN . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 4.0 tp . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' HH11 ' A' ' 32' ' ' ARG . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.479 HH12 HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.444 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 40' ' ' THR . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 62' ' ' ASN . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG22 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 16' ' ' TYR . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 15' ' ' THR . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' HD12 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.52 ' H ' HG22 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' NZ ' ' A' ' 72' ' ' LYS . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' NH1' ' A' ' 32' ' ' ARG . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ALA . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' A' ' 23' ' ' PRO . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.461 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' N ' ' HD3' ' A' ' 35' ' ' LYS . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.461 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.469 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.3 m-20 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' LYS . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.421 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -18.66 78.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -94.26 37.68 1.1 Allowed 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.472 1.13 . . . . 0.0 109.406 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.4 m 28.7 -126.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 112.79 -2.004 . . . . 0.0 113.786 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.8 p 44.45 26.77 0.19 Allowed 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 123.692 1.71 . . . . 0.0 111.051 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -135.67 4.45 3.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 110.62 -2.991 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.59 113.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 114.263 -2.78 . . . . 0.0 103.729 179.862 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD3' ' CG ' ' A' ' 72' ' ' LYS . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HD3' ' A' ' 23' ' ' PRO . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.508 ' H ' HG22 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp -101.76 155.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -117.67 152.46 35.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 123.733 0.646 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.8 m -140.3 166.56 24.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.631 1.207 . . . . 0.0 109.922 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m 93.4 -54.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -94.43 59.89 2.59 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.71 -43.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.824 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.496 1.851 0 C-N-CA 129.12 2.968 . . . . 0.0 106.128 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 41' ' ' THR . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 90' ' ' VAL . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 81' ' ' ILE . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 119.59 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -114.58 161.03 18.6 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.1 m -112.89 -178.42 3.38 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.876 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 m 122.99 -42.39 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -99.19 44.16 1.03 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' SG ' ' A' ' 48' ' ' CYS . 57.5 t -122.0 56.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.8 t . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 110.526 -3.034 . . . . 0.0 107.609 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 91' ' ' SER . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 89' ' ' ARG . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 79' ' ' TYR . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.98 165.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 87' ' ' CYS . 38.7 t70 -123.85 162.93 22.27 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.722 0.638 . . . . 0.0 110.349 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 86' ' ' ASP . 29.0 m -152.91 108.98 3.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 125.02 1.45 . . . . 0.0 107.089 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.5 p -148.8 84.22 1.47 Allowed 'General case' 0 C--N 1.296 -1.726 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . 2.6 ptm180 43.37 73.97 0.13 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.398 1.571 . . . . 0.0 107.109 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.73 40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.35 -3.114 . . . . 0.0 109.662 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 89' ' ' ARG . 19.6 m . . . . . 0 C--N 1.306 -1.311 0 CA-C-N 112.561 -2.109 . . . . 0.0 107.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 HH21 ' A' ' 45' ' ' ARG . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.414 HH21 HG22 ' A' ' 41' ' ' THR . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 9.6 tp -105.8 151.56 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.37 148.7 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.932 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 88' ' ' SER . 33.4 m -129.99 157.02 43.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 39.5 t 114.55 -37.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.29 -3.226 . . . . 0.0 102.29 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -93.59 47.05 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.28 -59.91 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 112.908 -1.951 . . . . 0.0 107.786 179.639 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 86' ' ' ASP . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.73 171.64 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 52' ' ' LYS . 26.4 t70 -130.72 -80.39 0.54 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 88' ' ' SER . 98.6 m 75.58 174.59 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.156 2.16 . . . . 0.0 108.704 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 7.3 t 144.26 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 89' ' ' ARG . 6.3 ptp180 -117.21 59.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.93 -31.45 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 111.201 -2.727 . . . . 0.0 113.357 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 116.115 -1.897 . . . . 0.0 115.475 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' SER . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ALA . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp -1.25 83.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -100.22 140.03 35.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.86 -173.01 2.22 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.388 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m 124.69 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 127.263 2.225 . . . . 0.0 108.09 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 52.16 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG21 ' SG ' ' A' ' 48' ' ' CYS . 61.0 t -121.67 73.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 112.203 -2.272 . . . . 0.0 107.924 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.835 -1.555 . . . . 0.0 111.543 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' CD ' ' HA ' ' A' ' 91' ' ' SER . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 65' ' ' ASN . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.38 166.86 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -114.58 102.4 10.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.137 0.898 . . . . 0.0 111.704 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 15.5 m -110.73 66.13 0.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' C ' ' HD2' ' A' ' 89' ' ' ARG . 47.0 t -137.21 73.85 1.46 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 88' ' ' SER . 2.8 mpt_? 63.76 75.97 0.37 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -83.22 -33.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 112.414 -2.175 . . . . 0.0 112.563 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . 34.9 t . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.411 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 4.0 tp -8.05 107.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.78 154.47 21.48 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 49' ' ' ASN . 10.6 m -105.07 61.71 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 125.631 2.634 . . . . 0.0 111.774 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.423 ' C ' ' HD2' ' A' ' 89' ' ' ARG . 14.4 p -121.13 -13.05 8.6 Favored 'General case' 0 C--N 1.289 -2.036 1 CA-C-N 108.208 -4.087 . . . . 0.0 110.285 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' HD2' ' N ' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -120.79 45.09 2.32 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 101.818 -3.401 . . . . 0.0 101.818 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.509 ' CG1' ' HG2' ' A' ' 44' ' ' ARG . 59.5 t -126.69 85.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.152 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.372 -1.299 . . . . 0.0 107.757 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HD2' ' H ' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp 3.14 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -93.98 63.99 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.578 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 m -30.64 128.27 0.14 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.923 -1.944 . . . . 0.0 113.2 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -172.92 -42.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.757 2.536 . . . . 0.0 108.009 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -122.66 75.47 1.27 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 111.998 -2.364 . . . . 0.0 108.831 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.9 t -106.94 -37.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 112.424 -2.171 . . . . 0.0 105.813 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.447 -1.263 . . . . 0.0 108.971 179.721 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' HH11 ' A' ' 32' ' ' ARG . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.479 HH12 HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.444 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 40' ' ' THR . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 62' ' ' ASN . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG22 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.9 159.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.9 168.49 11.42 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.03 0.919 . . . . 0.0 111.662 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' SER . 63.7 m -145.69 163.98 33.22 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.349 -2.205 . . . . 0.0 106.674 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 41.2 t 108.45 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -95.28 37.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.74 55.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 122.407 1.099 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 116.77 -1.586 . . . . 0.0 110.427 179.752 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 16' ' ' TYR . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 15' ' ' THR . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' HD12 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.52 ' H ' HG22 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.461 HH12 ' CB ' ' A' ' 91' ' ' SER . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.0 t-20 -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp -25.42 137.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.79 132.98 53.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.617 0.722 . . . . 0.0 110.728 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.5 m -131.21 171.42 13.33 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.251 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.5 p 123.68 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -125.29 69.45 1.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 91' ' ' SER . 5.3 p -88.33 -31.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.973 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.461 ' CB ' HH12 ' A' ' 44' ' ' ARG . 11.5 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 114.985 -2.436 . . . . 0.0 106.702 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' NZ ' ' A' ' 72' ' ' LYS . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' NH1' ' A' ' 32' ' ' ARG . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ALA . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' A' ' 23' ' ' PRO . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp -120.89 143.0 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -126.4 67.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 88' ' ' SER . 35.5 m -44.02 144.12 0.99 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 34.4 t 128.37 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.09 50.27 1.63 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.46 60.58 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 112.384 -2.189 . . . . 0.0 108.945 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.461 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' N ' ' HD3' ' A' ' 35' ' ' LYS . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.469 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -116.52 157.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 55.0 t0 -127.09 -48.75 1.46 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 86' ' ' ASP . 77.0 m 120.56 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 100.526 -3.879 . . . . 0.0 100.526 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -147.04 78.19 1.48 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.483 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 56.55 64.84 1.56 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.519 1.152 . . . . 0.0 108.033 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 t -89.44 64.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.933 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' LYS . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.421 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD3' ' CG ' ' A' ' 72' ' ' LYS . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HD3' ' A' ' 23' ' ' PRO . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.508 ' H ' HG22 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 41' ' ' THR . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 81' ' ' ILE . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' HZ2' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.404 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 79' ' ' TYR . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 HH21 ' A' ' 45' ' ' ARG . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.414 HH21 HG22 ' A' ' 41' ' ' THR . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 9.6 tp . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' SER . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ALA . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp . . . . . 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 65' ' ' ASN . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 4.0 tp . . . . . 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' HH11 ' A' ' 32' ' ' ARG . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.479 HH12 HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.444 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 40' ' ' THR . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 62' ' ' ASN . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.479 HG22 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.446 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.426 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 2' ' ' THR . 63.2 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 16' ' ' TYR . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 15' ' ' THR . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' HD12 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.52 ' H ' HG22 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' NZ ' ' A' ' 72' ' ' LYS . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' NH1' ' A' ' 32' ' ' ARG . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 71.6 m-80 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ALA . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' A' ' 23' ' ' PRO . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.461 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' N ' ' HD3' ' A' ' 35' ' ' LYS . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.461 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.469 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 20.2 tt . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 96.8 m -131.53 153.18 50.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.928 0.767 . . . . 0.0 110.085 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.59 -55.44 22.27 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.198 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -40.44 -52.27 3.65 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -54.07 -55.16 30.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 114.708 -0.746 . . . . 0.0 109.155 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.4 -48.7 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.194 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -50.91 -51.42 52.1 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.1 m -62.24 -54.83 35.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.871 -1.132 . . . . 0.0 109.73 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.34 -47.04 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -75.78 -14.41 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.68 -54.92 0.81 Allowed Glycine 0 N--CA 1.511 3.693 0 CA-C-N 119.452 1.024 . . . . 0.0 114.84 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.8 -44.39 31.76 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 123.304 2.669 . . . . 0.0 112.531 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 77.1 m -74.76 -49.04 22.4 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.267 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.0 mt -43.58 -45.55 6.75 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 68.2 m -48.58 -58.7 4.31 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -57.51 -58.34 8.73 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 113.922 -1.49 . . . . 0.0 108.935 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -39.15 -43.95 1.13 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.2 mtp180 -75.19 -51.99 12.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.295 -1.321 . . . . 0.0 108.148 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.19 49.91 0.01 OUTLIER Glycine 0 N--CA 1.496 2.646 0 C-N-CA 118.159 -1.972 . . . . 0.0 111.089 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.18 -166.6 13.24 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 105.648 -2.981 . . . . 0.0 105.648 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.93 165.37 16.81 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.25 -179.43 16.87 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 124.102 0.876 . . . . 0.0 112.602 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 72' ' ' LYS . 7.6 Cg_exo -76.08 167.48 80.07 Favored 'Cis proline' 0 C--N 1.317 -1.108 0 N-CA-C 109.02 -1.185 . . . . 0.0 109.02 8.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.3 t -118.21 169.55 9.61 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.813 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.01 -32.06 65.74 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.27 -44.4 79.45 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.547 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.2 t -63.69 -50.75 67.96 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.41 -60.94 2.68 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -47.3 -38.59 12.91 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -63.2 -57.81 14.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -50.7 -48.67 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 mtt85 -50.93 -54.72 21.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -49.12 -50.7 36.02 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -51.7 -57.95 7.76 Favored 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -45.12 -45.69 11.39 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 124.55 1.156 . . . . 0.0 111.459 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.44 -46.14 56.35 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.65 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.72 -43.37 85.24 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 123.456 0.702 . . . . 0.0 109.554 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.72 132.68 33.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.8 p -122.83 -38.76 2.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.842 0.714 . . . . 0.0 112.33 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 m -110.5 166.69 10.79 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.659 1.219 . . . . 0.0 111.471 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.421 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 25.3 p -47.72 -42.71 25.86 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 112.812 -1.995 . . . . 0.0 108.812 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.62 -57.62 11.62 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.15 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 49.6 m-20 -53.08 -51.96 60.14 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.006 -0.677 . . . . 0.0 110.309 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' NH1' ' HA ' ' A' ' 41' ' ' THR . 32.2 ttp-105 -49.42 -57.43 6.98 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.372 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -54.46 -49.35 70.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.643 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -49.39 -59.02 4.09 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.08 -53.55 41.03 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 28.9 t -42.11 -60.56 1.4 Allowed 'General case' 0 N--CA 1.507 2.421 0 CA-C-O 122.515 1.15 . . . . 0.0 111.213 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.02 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 86.6 m -46.73 -50.25 18.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.9 mt -60.05 -56.38 22.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -43.65 -52.48 6.38 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 123.601 0.563 . . . . 0.0 110.727 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -58.01 -55.84 29.7 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.329 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -50.03 -47.53 53.19 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.087 0.47 . . . . 0.0 111.568 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.19 28.42 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -109.61 -30.25 7.99 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.64 43.94 1.6 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.043 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.0 mt -125.07 102.55 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -97.41 34.23 1.85 Allowed 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 122.416 1.103 . . . . 0.0 108.786 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.11 -22.4 1.55 Allowed Glycine 0 N--CA 1.495 2.613 0 CA-C-N 112.764 -2.016 . . . . 0.0 110.579 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -41.65 146.54 0.23 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.288 1.035 . . . . 0.0 111.823 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -108.95 163.75 13.02 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.42 0.629 . . . . 0.0 111.412 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.86 -43.01 15.78 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.42 21.49 8.1 Favored Glycine 0 N--CA 1.503 3.105 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.946 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -122.39 -45.94 2.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.62 -48.82 68.96 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.41 22.95 1.41 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.692 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t -111.79 -25.59 9.39 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.731 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.2 mm -41.05 -54.47 5.58 Favored Pre-proline 0 N--CA 1.503 2.225 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.21 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 43.7 Cg_endo -57.42 -52.04 7.19 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.753 2.302 . . . . 0.0 112.006 171.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 26.9 t -51.64 -27.66 12.1 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 113.385 -1.734 . . . . 0.0 112.243 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 23' ' ' PRO . 29.8 mmtp -94.91 -49.88 5.37 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 124.17 0.919 . . . . 0.0 112.605 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.0 t -88.44 -65.91 0.97 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.832 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.4 83.6 1.25 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.89 -1.148 . . . . 0.0 112.496 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 t -107.3 -49.63 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.7 p 117.23 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 O-C-N 126.774 2.547 . . . . 0.0 111.16 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.37 152.13 52.26 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 57.5 Cg_endo -73.87 -40.22 1.48 Allowed 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 123.089 2.526 . . . . 0.0 113.137 171.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 1.3 p90 -118.27 155.23 30.95 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 112.445 -2.161 . . . . 0.0 107.937 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 81' ' ' ILE . 2.3 t -153.71 91.82 1.51 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 80' ' ' THR . 68.5 mt 31.28 66.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.676 0 O-C-N 123.746 0.654 . . . . 0.0 110.465 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 47.1 t -117.83 162.06 18.72 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.244 1.021 . . . . 0.0 112.705 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.42 -7.9 21.59 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -103.79 -53.27 2.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 123.774 0.671 . . . . 0.0 109.333 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -18.66 78.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -94.26 37.68 1.1 Allowed 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 122.472 1.13 . . . . 0.0 109.406 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.4 m 28.7 -126.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 112.79 -2.004 . . . . 0.0 113.786 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.8 p 44.45 26.77 0.19 Allowed 'General case' 0 N--CA 1.508 2.457 0 CA-C-O 123.692 1.71 . . . . 0.0 111.051 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -135.67 4.45 3.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 110.62 -2.991 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.1 t -121.59 113.72 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 114.263 -2.78 . . . . 0.0 103.729 179.862 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -114.17 -167.35 1.2 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.6 m -104.58 -9.01 18.58 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.41 -51.0 13.82 Favored Glycine 0 N--CA 1.491 2.312 1 N-CA-C 102.512 -4.235 . . . . 0.0 102.512 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -53.92 -37.37 63.74 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.246 -0.977 . . . . 0.0 108.529 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.56 -55.01 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -51.17 -46.46 62.09 Favored 'General case' 0 N--CA 1.503 2.197 0 C-N-CA 119.226 -0.989 . . . . 0.0 108.694 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.9 m -56.44 -52.87 63.05 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.61 -49.0 63.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 123.615 0.572 . . . . 0.0 111.198 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.0 m -76.99 -12.2 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.959 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -33.95 -46.52 0.46 Allowed Glycine 0 N--CA 1.505 3.252 0 N-CA-C 115.9 1.12 . . . . 0.0 115.9 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -73.87 -37.09 3.08 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 124.347 3.364 . . . . 0.0 115.388 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 76.3 m -72.85 -36.43 67.43 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 15' ' ' THR . 1.5 pp -44.32 -32.87 1.43 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 14' ' ' LEU . 90.1 m -56.09 -62.02 1.99 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -54.91 -55.57 29.09 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.038 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -45.93 -42.71 13.15 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -74.6 -44.79 49.07 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.834 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.2 57.22 0.02 OUTLIER Glycine 0 N--CA 1.496 2.645 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.39 11.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.18 172.03 10.22 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 129.1 -174.81 19.08 Favored Glycine 0 N--CA 1.492 2.385 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD3' ' CG ' ' A' ' 72' ' ' LYS . 2.9 Cg_exo -83.33 168.64 59.65 Favored 'Cis proline' 0 C--N 1.314 -1.251 0 N-CA-C 108.303 -1.46 . . . . 0.0 108.303 7.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 51.1 m -119.09 166.86 12.39 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.206 -1.361 . . . . 0.0 107.922 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.39 -56.47 5.83 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 125.036 1.46 . . . . 0.0 107.516 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.61 -53.45 18.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 125.519 1.762 . . . . 0.0 110.626 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.9 t -56.74 -57.12 13.83 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.968 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.449 ' SG ' ' NH2' ' A' ' 32' ' ' ARG . 1.1 t -52.28 -56.11 16.94 Favored 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.285 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 t -49.95 -42.97 49.7 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.3 -51.35 58.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.738 -1.745 . . . . 0.0 108.738 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.67 -51.06 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' SG ' ' A' ' 28' ' ' CYS . 46.8 mtt180 -46.47 -53.78 10.52 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.7 m -59.28 -49.4 77.97 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.575 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.9 tp -44.65 -60.75 1.85 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -49.95 -59.68 3.64 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 112.18 -2.282 . . . . 0.0 110.02 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.6 -54.13 10.08 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.043 0.839 . . . . 0.0 113.243 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.03 -42.52 76.24 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 123.852 0.72 . . . . 0.0 111.837 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.58 75.13 5.89 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.788 0.804 . . . . 0.0 109.686 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.1 m -117.29 -60.12 1.86 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.684 -1.598 . . . . 0.0 111.942 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -44.49 140.25 2.43 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 118.546 -0.74 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 p -32.68 -56.29 0.36 Allowed 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.11 -59.25 5.36 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.511 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 26.2 m-20 -55.54 -44.7 76.97 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.557 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -54.7 -55.77 26.28 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -52.82 -51.4 61.0 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.1 m -50.45 -60.08 3.36 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.247 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.92 -54.67 26.74 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 47.8 t -41.86 -59.41 1.71 Allowed 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.919 0.866 . . . . 0.0 110.479 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -58.63 -54.05 51.45 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.3 m -43.31 -51.69 6.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 123.739 0.65 . . . . 0.0 109.63 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.57 -53.35 57.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.873 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -42.86 -54.78 4.0 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.14 -54.4 44.9 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.133 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -45.7 -49.45 14.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.79 -56.77 17.6 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -46.9 -31.4 3.1 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.673 0.608 . . . . 0.0 111.791 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -96.14 24.45 30.06 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 117.594 1.797 . . . . 0.0 117.594 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 92.4 mt -115.08 153.11 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -111.96 -36.98 5.23 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.469 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.41 50.68 0.87 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.2 tp -86.59 156.13 20.17 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -110.86 97.68 7.01 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -43.11 -30.25 0.43 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 124.857 1.348 . . . . 0.0 113.231 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.4 -17.78 9.67 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 114.581 -1.191 . . . . 0.0 115.715 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -103.06 -31.5 10.15 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.125 1.463 . . . . 0.0 112.438 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.53 -39.81 81.01 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.23 18.58 1.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 113.415 -1.72 . . . . 0.0 110.842 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.9 m -122.44 -20.31 6.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 117.73 -1.128 . . . . 0.0 113.161 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.8 mm -38.97 -55.95 2.65 Favored Pre-proline 0 N--CA 1.515 2.776 0 CA-C-N 119.56 1.073 . . . . 0.0 113.32 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 34.5 Cg_endo -52.49 -48.26 22.78 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 123.502 2.801 . . . . 0.0 111.452 -175.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.3 t -69.35 -46.92 65.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 126.466 2.354 . . . . 0.0 110.801 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' CG ' ' HD3' ' A' ' 23' ' ' PRO . 23.0 tptm -52.07 -51.08 59.92 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.619 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 t -94.37 -51.41 4.79 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.555 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.16 56.21 0.3 Allowed Glycine 0 N--CA 1.504 3.187 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -121.34 57.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 101.495 -3.521 . . . . 0.0 101.495 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -31.89 89.37 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 112.932 -1.94 . . . . 0.0 114.228 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -110.47 151.35 42.66 Favored Pre-proline 0 N--CA 1.501 2.095 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.389 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -56.65 -43.59 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.591 2.861 . . . . 0.0 114.515 -177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.435 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.5 p90 -126.75 152.88 46.26 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 111.944 -2.389 . . . . 0.0 111.36 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 81' ' ' ILE . 51.7 m -135.77 -172.17 3.03 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.717 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.508 ' H ' HG22 ' A' ' 80' ' ' THR . 76.0 mt -81.83 75.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.3 t -110.8 179.58 4.02 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 112.767 -2.015 . . . . 0.0 109.268 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.35 -45.09 4.97 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.5 p -110.79 54.61 0.67 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 122.191 0.996 . . . . 0.0 112.618 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.8 tp -101.76 155.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-N 113.116 -1.856 . . . . 0.0 107.907 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -117.67 152.46 35.16 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 123.733 0.646 . . . . 0.0 111.229 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 59.8 m -140.3 166.56 24.36 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 124.631 1.207 . . . . 0.0 109.922 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m 93.4 -54.0 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -94.43 59.89 2.59 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 p -110.71 -43.04 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-N 112.174 -2.285 . . . . 0.0 105.824 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.496 1.851 0 C-N-CA 129.12 2.968 . . . . 0.0 106.128 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 N--CA 1.498 1.961 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.8 p -125.65 162.57 24.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.076 0.86 . . . . 0.0 109.561 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -62.85 -52.56 62.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -38.23 -52.32 2.22 Favored Glycine 0 N--CA 1.504 3.2 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -56.65 -55.18 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 114.263 -0.969 . . . . 0.0 109.082 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.3 t -53.79 -51.2 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -50.98 -50.67 57.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.7 m -62.53 -50.4 71.51 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.18 -45.43 61.78 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.82 -12.61 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 119.027 -1.069 . . . . 0.0 113.671 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -32.26 -58.76 0.4 Allowed Glycine 0 N--CA 1.511 3.654 0 CA-C-N 119.261 0.937 . . . . 0.0 114.533 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 45.6 Cg_exo -46.0 -24.89 2.47 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 124.505 3.47 . . . . 0.0 115.94 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.8 m -101.85 -40.97 6.68 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 125.476 1.51 . . . . 0.0 108.68 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.4 tp -41.22 -43.27 2.32 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.329 -0.85 . . . . 0.0 113.121 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.0 p -50.55 -58.69 5.21 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.05 -51.23 70.93 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.868 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.92 -26.27 46.92 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.569 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -81.26 -52.03 7.76 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.677 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.87 51.45 0.05 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -122.97 -158.44 10.21 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.42 14.82 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.904 -0.719 . . . . 0.0 110.328 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.07 -168.53 19.97 Favored Glycine 0 N--CA 1.494 2.567 0 O-C-N 125.149 1.531 . . . . 0.0 109.656 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -82.1 157.28 79.34 Favored 'Cis proline' 0 C--N 1.315 -1.23 0 N-CA-C 107.724 -1.683 . . . . 0.0 107.724 -2.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.2 t -124.31 178.54 5.31 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.962 0.886 . . . . 0.0 110.606 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 -30.78 63.79 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.33 -47.67 72.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.083 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.2 t -57.74 -53.39 58.78 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.32 -56.84 10.91 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.262 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -44.81 -47.43 10.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.16 -54.05 40.56 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.6 -45.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -53.85 -52.68 59.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -46.71 -54.94 8.61 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.4 mp -49.96 -58.92 4.45 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.757 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 13.3 mmmm -44.83 -40.64 6.34 Favored 'General case' 0 N--CA 1.507 2.401 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.54 -44.55 28.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.187 0.929 . . . . 0.0 111.499 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.77 -42.4 79.35 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -86.69 134.47 33.6 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.7 p -118.36 -50.76 2.43 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 p -116.53 173.15 6.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 41' ' ' THR . 49.8 p -41.81 -42.73 2.75 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 113.242 -1.799 . . . . 0.0 112.005 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.77 -56.37 22.78 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.891 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 22.6 m-20 -56.06 -51.28 68.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 46.6 ttm180 -47.67 -56.44 7.25 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.141 -1.39 . . . . 0.0 110.131 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 63.9 mtm-85 -57.86 -48.97 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.251 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -49.9 -54.67 18.18 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.0 -57.97 9.03 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' A' ' 90' ' ' VAL . 52.9 t -39.01 -58.96 1.04 Allowed 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 122.452 1.12 . . . . 0.0 112.705 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' ND2' ' SG ' ' A' ' 87' ' ' CYS . 31.7 m-80 -64.95 -49.55 69.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.817 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 22.6 m -46.06 -48.86 16.91 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.544 0.688 . . . . 0.0 109.189 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.41 -54.75 35.63 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -44.12 -51.99 7.59 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-O 122.215 1.007 . . . . 0.0 109.205 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -60.84 2.86 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.637 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.18 -50.91 35.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.516 1.135 . . . . 0.0 113.171 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.86 10.58 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.3 mtm180 -118.1 -10.25 10.36 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 119.712 -0.185 . . . . 0.0 110.611 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -128.99 45.88 1.11 Allowed Glycine 0 N--CA 1.491 2.326 0 CA-C-O 119.515 -0.603 . . . . 0.0 112.921 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 mt -123.27 37.76 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -10.4 82.85 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.16 43.19 0.52 Allowed Glycine 0 N--CA 1.499 2.856 0 CA-C-N 115.422 -0.808 . . . . 0.0 113.862 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.6 tp -90.39 165.88 13.6 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.52 142.97 29.45 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.502 -0.879 . . . . 0.0 108.974 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.5 -31.12 26.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.305 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.21 -3.19 21.4 Favored Glycine 0 N--CA 1.495 2.625 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.798 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -105.93 -38.32 6.37 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.18 84.49 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.63 20.06 1.84 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.223 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.0 t -116.35 -29.38 6.22 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.658 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.546 HD12 ' SG ' ' A' ' 27' ' ' CYS . 15.2 mm -38.91 -58.71 1.62 Allowed Pre-proline 0 N--CA 1.507 2.403 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 74' ' ' GLY . 41.0 Cg_endo -57.75 -52.55 5.89 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.354 2.036 . . . . 0.0 111.021 178.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.7 t -52.47 -37.09 56.29 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.901 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -78.71 -48.86 14.13 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.59 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 48.9 t -84.64 -60.01 2.19 Favored 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 113.11 55.48 0.44 Allowed Glycine 0 N--CA 1.499 2.896 0 O-C-N 123.897 0.748 . . . . 0.0 114.93 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -116.74 62.76 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.0 p -33.98 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.416 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.7 m -117.48 151.34 48.07 Favored Pre-proline 0 N--CA 1.507 2.409 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.491 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 56.1 Cg_endo -56.88 -41.21 77.85 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 123.765 2.976 . . . . 0.0 114.418 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CE2' ' HG2' ' A' ' 78' ' ' PRO . 0.6 OUTLIER -112.86 151.17 30.74 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 112.105 -2.316 . . . . 0.0 107.398 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.449 ' O ' ' C ' ' A' ' 81' ' ' ILE . 60.7 m -141.84 73.03 1.4 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.463 HD12 ' N ' ' A' ' 81' ' ' ILE . 4.6 mp 32.04 52.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-O 123.108 1.432 . . . . 0.0 108.574 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.5 t -116.72 163.44 16.13 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 113.723 -1.581 . . . . 0.0 112.854 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.21 -8.54 21.23 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 113.235 -1.802 . . . . 0.0 106.795 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -116.99 46.11 1.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.677 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 119.59 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.129 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -114.58 161.03 18.6 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' SG ' ' ND2' ' A' ' 49' ' ' ASN . 8.1 m -112.89 -178.42 3.38 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.113 -0.948 . . . . 0.0 108.876 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 m 122.99 -42.39 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -99.19 44.16 1.03 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 ' SG ' ' A' ' 48' ' ' CYS . 57.5 t -122.0 56.37 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.8 t . . . . . 0 N--CA 1.5 2.046 0 CA-C-N 110.526 -3.034 . . . . 0.0 107.609 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.3 p -124.22 158.58 32.11 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.2 m -60.53 -39.31 87.38 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.426 -1.31 . . . . 0.0 109.136 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -47.1 -54.07 10.13 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -54.91 -49.61 70.83 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.498 -0.851 . . . . 0.0 109.001 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 62.2 t -54.24 -48.61 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.162 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.52 -52.66 53.61 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -52.71 -52.38 56.34 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.357 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.0 -50.18 67.19 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.43 -24.53 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -28.16 -60.75 0.12 Allowed Glycine 0 N--CA 1.513 3.785 0 CA-C-N 119.932 1.242 . . . . 0.0 115.018 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 86.0 Cg_exo -51.87 -28.58 31.69 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 124.049 3.166 . . . . 0.0 114.269 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.9 m -90.27 -42.33 11.05 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 125.588 1.555 . . . . 0.0 109.023 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.0 tp -41.4 -48.09 3.7 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.514 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.1 t -51.03 -48.71 61.42 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -66.83 -48.73 67.97 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.52 -30.83 21.7 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 123.967 0.792 . . . . 0.0 111.169 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -80.23 -52.14 8.09 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.006 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.99 65.6 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.39 178.42 16.57 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.8 68.73 6.43 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.396 1.093 . . . . 0.0 109.93 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.83 -160.98 11.07 Favored Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.148 -1.842 . . . . 0.0 110.563 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.46 -179.07 25.28 Favored 'Cis proline' 0 N--CA 1.495 1.561 0 O-C-N 122.998 0.999 . . . . 0.0 111.071 -7.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -130.58 166.37 20.78 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 123.275 1.512 . . . . 0.0 112.954 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.11 -29.77 70.55 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 104.554 -2.387 . . . . 0.0 104.554 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.42 -44.89 81.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 12' ' ' PRO . 2.1 t -58.39 -53.11 62.01 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 51.1 m -49.15 -61.52 2.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.671 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -44.6 -46.28 9.98 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.44 -50.69 64.02 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 58.3 t -59.02 -44.11 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 118.573 1.187 . . . . 0.0 107.869 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtt-85 -52.42 -55.99 18.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.823 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 95.9 p -59.08 -45.26 91.28 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.257 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 47.3 tp -43.25 -62.91 0.92 Allowed 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' HZ2' ' A' ' 35' ' ' LYS . 3.4 mmmp? -58.42 -52.65 64.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.921 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -42.39 -54.03 3.98 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.608 0.567 . . . . 0.0 110.908 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.21 -47.86 75.4 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.994 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -98.7 72.07 1.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 122.423 1.106 . . . . 0.0 109.283 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.3 p -115.38 9.03 15.49 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 112.607 -2.088 . . . . 0.0 113.286 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.0 m -119.4 156.65 29.73 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -32.04 -67.67 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.824 1.787 . . . . 0.0 115.824 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.8 -56.0 25.78 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 113.238 -1.801 . . . . 0.0 110.922 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-20 -53.07 -52.44 58.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 123.858 0.724 . . . . 0.0 112.155 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 91' ' ' SER . 49.0 ttp180 -50.24 -56.05 12.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 89' ' ' ARG . 36.0 mtp180 -55.05 -50.23 69.62 Favored 'General case' 0 N--CA 1.504 2.246 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.844 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.2 m -49.52 -57.81 6.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.05 -55.23 18.57 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.2 t -39.01 -58.37 1.12 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.847 0.832 . . . . 0.0 109.81 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 67.5 m-80 -59.72 -57.45 12.88 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.524 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.6 m -41.73 -44.93 3.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.264 0.977 . . . . 0.0 109.829 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 79' ' ' TYR . 75.7 mt -70.11 -55.89 8.29 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -43.44 -44.78 6.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 124.289 0.993 . . . . 0.0 111.21 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.64 -53.2 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.255 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.81 -48.42 20.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 123.833 0.708 . . . . 0.0 111.672 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.58 35.79 0.1 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -114.42 -39.3 3.86 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.505 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.69 43.56 1.57 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.012 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.8 mt -107.84 55.74 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -20.81 76.23 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 CA-C-N 111.713 -2.494 . . . . 0.0 116.357 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.0 47.32 0.44 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 50.7 tp -87.63 161.44 17.69 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -96.72 159.12 15.1 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.46 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.99 -55.24 4.33 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 113.624 -1.625 . . . . 0.0 112.897 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.32 41.04 2.13 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 124.002 0.814 . . . . 0.0 112.645 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -131.23 -49.75 1.01 Allowed 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.48 -48.43 75.24 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' HG21 ' A' ' 80' ' ' THR . . . -83.36 23.17 0.94 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.187 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.4 t -119.17 -30.15 5.04 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 12.7 mm -37.89 -53.63 2.63 Favored Pre-proline 0 N--CA 1.503 2.212 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.633 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.4 Cg_endo -54.8 -52.46 7.99 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 122.412 2.074 . . . . 0.0 110.408 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.1 t -55.6 -48.13 75.37 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.835 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -59.57 -52.15 66.78 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.372 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 42.5 t -87.68 -65.0 1.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.69 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 70' ' ' PRO . . . 109.83 71.55 0.68 Allowed Glycine 0 N--CA 1.5 2.93 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.829 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -117.05 24.99 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 119.343 -0.943 . . . . 0.0 108.826 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 30.74 86.94 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 m -115.78 160.77 33.74 Favored Pre-proline 0 N--CA 1.502 2.128 0 CA-C-O 119.278 -0.392 . . . . 0.0 111.926 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -106.17 35.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 124.677 3.584 . . . . 0.0 111.898 178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.7 p90 165.46 156.52 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 81' ' ' ILE . 98.0 m -137.29 -170.24 2.68 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' THR . 66.0 mt -82.85 71.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 1 N-CA-C 99.176 -4.379 . . . . 0.0 99.176 179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.2 t -111.7 144.89 40.24 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 112.421 -2.172 . . . . 0.0 109.55 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.12 12.28 37.33 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.486 -2.412 . . . . 0.0 104.486 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.9 p -143.15 50.52 1.41 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.0 tp -120.98 165.91 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.402 ' CG ' ' N ' ' A' ' 87' ' ' CYS . 38.7 t70 -123.85 162.93 22.27 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.722 0.638 . . . . 0.0 110.349 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.402 ' N ' ' CG ' ' A' ' 86' ' ' ASP . 29.0 m -152.91 108.98 3.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 125.02 1.45 . . . . 0.0 107.089 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.5 p -148.8 84.22 1.47 Allowed 'General case' 0 C--N 1.296 -1.726 1 N-CA-C 99.696 -4.187 . . . . 0.0 99.696 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.53 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . 2.6 ptm180 43.37 73.97 0.13 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 123.398 1.571 . . . . 0.0 107.109 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 p -80.73 40.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 CA-C-N 110.35 -3.114 . . . . 0.0 109.662 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 89' ' ' ARG . 19.6 m . . . . . 0 C--N 1.306 -1.311 0 CA-C-N 112.561 -2.109 . . . . 0.0 107.918 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.9 p -126.14 158.64 35.0 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.8 m -55.2 -45.08 75.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.294 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.24 -52.03 8.71 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -56.29 -50.11 72.33 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.3 t -54.64 -51.85 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.364 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -50.75 -50.32 55.89 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.7 m -58.65 -53.51 57.57 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.691 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.79 -49.14 49.74 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.909 0.755 . . . . 0.0 111.913 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -76.43 -16.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 123.77 0.669 . . . . 0.0 111.555 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.63 -59.81 0.08 OUTLIER Glycine 0 N--CA 1.507 3.405 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -61.38 -38.77 61.88 Favored 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 124.521 3.48 . . . . 0.0 114.171 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m -70.26 -38.04 75.05 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.095 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.9 mt -42.04 -42.07 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 42.2 m -49.8 -58.7 4.85 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -61.54 -53.62 53.97 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.165 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -41.2 -43.56 2.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.203 0.939 . . . . 0.0 112.824 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -76.65 -52.02 10.46 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.03 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.57 49.94 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 C-N-CA 118.825 -1.655 . . . . 0.0 110.909 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.25 -167.14 12.79 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.32 167.74 21.3 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.788 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.13 -171.65 15.36 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 124.203 0.939 . . . . 0.0 110.819 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.5 155.0 85.38 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 N-CA-C 106.839 -2.023 . . . . 0.0 106.839 -2.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.0 m -127.24 177.58 6.6 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.251 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.08 -53.41 1.81 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 125.403 1.689 . . . . 0.0 110.309 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.36 -48.68 71.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 124.114 0.884 . . . . 0.0 112.641 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.5 t -62.73 -53.93 46.97 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.454 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.01 -55.34 21.11 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.347 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -47.57 -50.99 22.52 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.59 -53.44 38.84 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.5 t -53.89 -49.97 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-O 122.238 1.018 . . . . 0.0 108.266 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.1 mtt180 -50.11 -52.03 38.24 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.233 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -56.6 -47.31 79.89 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.08 -60.23 2.2 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -50.7 -59.11 4.41 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.044 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.71 -49.98 3.08 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.16 -46.96 47.78 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.039 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -87.69 85.71 7.1 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.3 p -108.21 -20.42 13.15 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 112.411 -2.177 . . . . 0.0 113.926 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.2 p -102.23 160.75 14.26 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 122.759 1.266 . . . . 0.0 111.488 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 HH21 ' A' ' 45' ' ' ARG . 21.4 m -45.35 -51.17 11.52 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 112.61 -2.086 . . . . 0.0 110.714 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.39 -54.2 48.42 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 112.596 -2.093 . . . . 0.0 108.38 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 75.3 m-20 -50.74 -54.82 20.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.179 0.924 . . . . 0.0 109.87 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -49.31 -58.64 4.72 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.813 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.414 HH21 HG22 ' A' ' 41' ' ' THR . 14.5 mtm180 -57.5 -46.0 84.28 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.085 -1.446 . . . . 0.0 111.286 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -51.07 -57.86 7.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.69 -55.2 20.91 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 44.9 t -41.16 -58.7 1.71 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-O 121.986 0.898 . . . . 0.0 109.989 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -58.98 -54.11 50.78 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.954 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 56.8 m -42.7 -49.67 5.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.09 -54.28 36.49 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE3' ' SG ' ' A' ' 87' ' ' CYS . 35.6 ttmt -41.35 -45.89 3.16 Favored 'General case' 0 N--CA 1.509 2.481 0 O-C-N 124.05 0.844 . . . . 0.0 109.664 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -71.68 -55.94 6.75 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.262 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -46.06 -44.01 15.04 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.21 -2.5 0.1 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.1 mtt180 -95.19 57.28 2.0 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.1 65.6 0.25 Allowed Glycine 0 N--CA 1.49 2.289 0 CA-C-N 115.327 -0.851 . . . . 0.0 114.526 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 43.4 mt -108.31 74.08 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 103.232 -2.877 . . . . 0.0 103.232 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 63.5 mttp 11.65 60.93 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 CA-C-N 112.131 -2.304 . . . . 0.0 116.564 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 57.47 1.02 Allowed Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.4 tp -71.19 156.74 39.21 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -104.94 158.9 16.22 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.791 0.805 . . . . 0.0 111.805 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.38 -42.78 14.24 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.456 -1.702 . . . . 0.0 112.092 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.83 26.02 6.98 Favored Glycine 0 N--CA 1.499 2.872 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.519 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -131.43 -43.2 1.03 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.75 61.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.44 25.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.086 -1.87 . . . . 0.0 111.336 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.2 m -115.89 -25.45 7.72 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.949 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm -39.67 -57.52 2.48 Favored Pre-proline 0 N--CA 1.507 2.412 0 CA-C-N 118.456 0.571 . . . . 0.0 111.859 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 38.3 Cg_endo -54.51 -50.13 14.48 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 123.525 2.817 . . . . 0.0 111.648 -178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.3 m -58.62 -47.61 83.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 126.482 2.364 . . . . 0.0 112.372 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -68.11 -51.28 48.06 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.504 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 10.5 m -67.97 -51.23 49.73 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.01 51.59 0.83 Allowed Glycine 0 N--CA 1.496 2.68 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.23 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -117.04 63.18 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 102.446 -3.168 . . . . 0.0 102.446 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.1 p -33.09 87.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.876 -1.966 . . . . 0.0 115.192 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.01 153.48 43.16 Favored Pre-proline 0 N--CA 1.507 2.393 0 C-N-CA 121.135 -0.226 . . . . 0.0 111.424 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 74.0 Cg_endo -61.37 -48.65 9.17 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 123.524 2.816 . . . . 0.0 114.058 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 9.9 p90 -120.76 158.37 27.67 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 111.587 -2.551 . . . . 0.0 110.486 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.3 t -145.95 -156.26 0.69 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.4 mt -87.87 78.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 14.3 t -107.65 173.44 6.32 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.973 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.52 -20.49 14.47 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 113.808 -1.542 . . . . 0.0 110.409 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -133.96 63.41 1.63 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 123.566 0.541 . . . . 0.0 110.577 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 9.6 tp -105.8 151.56 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.857 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -126.37 148.7 49.55 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.682 -1.145 . . . . 0.0 108.932 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 88' ' ' SER . 33.4 m -129.99 157.02 43.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 104.458 -2.423 . . . . 0.0 104.458 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 39.5 t 114.55 -37.28 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.29 -3.226 . . . . 0.0 102.29 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -93.59 47.05 1.21 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 99.6 t -124.28 -59.91 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 102.815 -3.031 . . . . 0.0 102.815 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-N 112.908 -1.951 . . . . 0.0 107.786 179.639 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.7 tt . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.5 m -133.3 153.64 51.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 123.816 0.698 . . . . 0.0 109.955 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 70.8 m -53.59 -50.8 64.84 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.69 -51.63 5.65 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -53.36 -50.02 65.94 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.12 -52.18 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.201 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -50.93 -45.52 60.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 123.338 0.399 . . . . 0.0 110.68 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 p -70.35 -43.59 69.88 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.452 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.42 -50.11 65.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 m -79.53 24.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.712 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.87 -56.02 2.84 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -41.58 -33.72 1.87 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.791 2.327 . . . . 0.0 112.301 164.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 99.0 m -82.01 -44.3 16.83 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.712 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.46 -42.05 4.62 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 119.048 -0.501 . . . . 0.0 111.946 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.8 m -51.88 -62.33 1.7 Allowed 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' CE2' ' O ' ' A' ' 65' ' ' ASN . 65.2 t80 -53.51 -49.06 68.35 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.213 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -56.71 -31.54 64.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 124.381 1.051 . . . . 0.0 112.905 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -73.12 -47.82 40.97 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.45 68.85 0.02 OUTLIER Glycine 0 N--CA 1.498 2.784 0 CA-C-N 115.056 -0.974 . . . . 0.0 112.349 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.53 179.83 16.63 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.63 63.07 5.34 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -117.15 -162.76 12.76 Favored Glycine 0 CA--C 1.545 1.938 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.745 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -70.57 -178.24 17.55 Favored 'Cis proline' 0 N--CA 1.492 1.402 0 O-C-N 123.129 1.068 . . . . 0.0 110.413 -3.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.7 t -123.8 166.49 15.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.2 -37.78 67.53 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.72 93.18 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.139 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 19.9 t -67.33 -51.29 54.22 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.661 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 93.3 m -52.13 -54.77 26.54 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.3 t -49.96 -49.57 49.8 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.4 -46.74 91.55 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.831 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.77 -51.45 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -47.4 -56.75 6.31 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.209 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.4 p -65.92 -34.09 77.32 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.658 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 tt -53.24 -58.5 6.84 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -56.24 -53.44 57.22 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 112.923 -1.944 . . . . 0.0 111.076 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.66 -49.99 25.91 Favored 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.581 0.705 . . . . 0.0 109.609 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 39' ' ' SER . . . -62.72 -33.75 75.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 113.982 -1.463 . . . . 0.0 108.656 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.689 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.55 46.37 1.38 Allowed 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 123.232 1.491 . . . . 0.0 107.366 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 37' ' ' ALA . 29.1 t -31.74 -67.42 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 119.498 3.147 . . . . 0.0 119.498 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -115.17 169.45 9.11 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.83 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.2 m -33.29 -51.47 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.784 -1.553 . . . . 0.0 115.064 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.28 -56.67 17.34 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.546 0.688 . . . . 0.0 109.542 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.9 m-20 -54.17 -52.09 62.28 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.43 -1.259 . . . . 0.0 109.237 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 37.6 ttm105 -46.75 -57.03 5.25 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.426 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -53.94 -50.72 65.82 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.0 m -52.06 -64.43 0.82 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.518 1.136 . . . . 0.0 108.599 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.8 -55.94 5.96 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 44.9 t -43.96 -60.4 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.937 0.875 . . . . 0.0 112.16 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -66.41 -40.11 89.41 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.238 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 57.9 m -51.43 -51.36 55.54 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.71 -55.25 36.64 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 86' ' ' ASP . 33.1 ttpt -43.11 -50.92 6.1 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.603 0.564 . . . . 0.0 111.23 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -65.66 -49.39 68.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 124.442 1.089 . . . . 0.0 109.683 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.52 -42.23 32.57 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.97 36.74 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.8 ttp85 -119.93 48.7 1.5 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 119.39 70.34 0.33 Allowed Glycine 0 N--CA 1.494 2.538 0 CA-C-N 114.445 -1.252 . . . . 0.0 116.154 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.2 mt -108.21 54.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 N-CA-C 103.161 -2.903 . . . . 0.0 103.161 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -8.77 70.73 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 111.846 -2.434 . . . . 0.0 115.489 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.69 46.84 0.55 Allowed Glycine 0 N--CA 1.495 2.616 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.135 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 43.9 tp -88.69 152.12 22.0 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.21 102.27 14.32 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.295 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.9 -28.49 2.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.844 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.87 -15.05 8.86 Favored Glycine 0 N--CA 1.499 2.852 0 N-CA-C 115.491 0.957 . . . . 0.0 115.491 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.418 ' O ' ' CE2' ' A' ' 16' ' ' TYR . 27.8 t30 -109.13 -18.91 13.53 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.958 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -82.94 -47.16 12.08 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.88 11.5 0.52 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.054 -1.884 . . . . 0.0 112.389 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.5 p -115.78 -2.7 12.34 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 1.5 mm -43.75 -52.14 15.18 Favored Pre-proline 0 N--CA 1.501 2.124 0 CA-C-O 118.603 -0.713 . . . . 0.0 112.068 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.9 Cg_endo -55.25 -50.46 12.92 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.491 2.127 . . . . 0.0 110.832 175.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -51.84 -43.41 63.19 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 113.232 -1.804 . . . . 0.0 111.618 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -80.34 -50.39 10.22 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 m -77.44 -60.09 2.51 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.62 51.57 0.75 Allowed Glycine 0 N--CA 1.502 3.034 0 O-C-N 123.672 0.608 . . . . 0.0 112.819 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.4 68.7 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.2 p -33.58 96.14 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.678 -1.601 . . . . 0.0 113.885 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.1 151.72 45.17 Favored Pre-proline 0 N--CA 1.505 2.316 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 39.3 Cg_endo -55.05 -44.47 49.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 123.832 3.022 . . . . 0.0 112.897 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 6.8 p90 -115.41 154.84 28.5 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 110.999 -2.818 . . . . 0.0 108.61 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 t -154.32 90.31 1.33 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 68.0 mt 32.57 62.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 123.878 0.736 . . . . 0.0 110.767 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.1 t -123.65 158.14 32.21 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.04 22.22 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 61.4 p -123.79 48.54 1.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 124.055 0.847 . . . . 0.0 112.616 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -115.73 171.64 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.401 ' HA ' ' NZ ' ' A' ' 52' ' ' LYS . 26.4 t70 -130.72 -80.39 0.54 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 88' ' ' SER . 98.6 m 75.58 174.59 0.24 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 126.156 2.16 . . . . 0.0 108.704 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 7.3 t 144.26 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.447 ' H ' ' HG2' ' A' ' 89' ' ' ARG . 6.3 ptp180 -117.21 59.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 100.525 -3.88 . . . . 0.0 100.525 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.93 -31.45 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-N 111.201 -2.727 . . . . 0.0 113.357 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 116.115 -1.897 . . . . 0.0 115.475 -179.874 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 13.8 tt . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 81.1 p -136.12 162.86 31.76 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.8 m -57.32 -44.65 84.39 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.295 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -45.42 -53.38 8.16 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.29 -51.28 65.13 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 114.402 -0.899 . . . . 0.0 109.015 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.0 t -53.88 -51.34 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.725 -0.79 . . . . 0.0 110.206 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -51.79 -49.64 62.29 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 26.4 t -56.6 -50.41 72.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.706 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.47 -47.59 78.86 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.958 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -76.2 -8.24 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.974 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -34.07 -51.5 0.68 Allowed Glycine 0 N--CA 1.503 3.105 0 O-C-N 124.16 0.912 . . . . 0.0 113.815 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -73.74 -34.46 5.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 124.738 3.625 . . . . 0.0 115.807 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 73.8 m -72.15 -43.29 64.85 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 3.3 pp -44.14 -36.62 2.69 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 14' ' ' LEU . 36.8 m -53.22 -59.88 4.0 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -56.81 -56.84 16.4 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.989 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -41.96 -41.54 2.52 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.89 1.369 . . . . 0.0 114.072 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 mtp85 -77.12 -49.43 15.25 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.273 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.79 51.68 0.03 OUTLIER Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.51 -158.36 10.34 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 106.113 -2.795 . . . . 0.0 106.113 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.95 167.94 13.82 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.783 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.04 -170.53 15.03 Favored Glycine 0 N--CA 1.498 2.788 0 O-C-N 124.268 0.98 . . . . 0.0 111.07 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -72.33 163.45 87.94 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 O-C-N 123.274 1.144 . . . . 0.0 109.44 -2.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.4 t -121.71 169.82 10.34 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.69 -35.44 55.49 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.42 75.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 69' ' ' ILE . 8.3 t -59.79 -51.61 68.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 74.8 m -50.07 -57.71 7.06 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 34.3 t -46.55 -48.28 19.47 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.83 -53.97 36.28 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.1 t -53.03 -49.51 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 29' ' ' SER . 46.3 mtt180 -49.96 -52.2 35.41 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.283 -1.326 . . . . 0.0 107.621 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.9 t -56.79 -50.92 70.88 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 64.5 mt -45.08 -59.68 2.48 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -48.4 -62.37 1.53 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.983 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.74 -55.01 2.52 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.479 1.112 . . . . 0.0 112.658 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.45 -41.9 96.28 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.604 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -78.58 72.41 5.11 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.4 t -96.6 -47.4 5.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.28 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.6 p -93.08 166.27 12.43 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.471 -0.891 . . . . 0.0 109.305 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -55.64 -41.6 73.81 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -55.52 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 16.2 m-20 -52.53 -52.93 52.4 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.238 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.8 ttm105 -48.71 -56.94 7.13 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.508 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -53.35 -51.62 61.88 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.2 m -49.4 -58.17 5.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 124.622 1.201 . . . . 0.0 107.872 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.81 -57.48 10.76 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 118.976 -0.535 . . . . 0.0 109.831 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 53.7 t -41.31 -57.54 2.11 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 122.247 1.023 . . . . 0.0 111.153 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 75.7 m-80 -58.08 -52.91 63.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.288 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.5 m -47.68 -48.38 29.23 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.332 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -60.54 -54.89 39.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 tppt? -43.99 -55.99 4.27 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.613 0.72 . . . . 0.0 109.661 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 56' ' ' ARG . 47.5 t30 -57.03 -52.53 64.92 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.347 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -47.93 -53.43 15.93 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.228 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.1 50.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 124.039 0.837 . . . . 0.0 110.287 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 22.2 ttt180 -22.17 -47.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.59 34.85 4.22 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 118.257 2.063 . . . . 0.0 118.257 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 54' ' ' ALA . 61.8 mt -101.26 67.96 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -16.91 -52.41 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.058 -2.337 . . . . 0.0 115.799 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -110.71 58.69 0.38 Allowed Glycine 0 N--CA 1.498 2.807 0 O-C-N 123.991 0.807 . . . . 0.0 113.362 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.9 tp -90.74 165.75 13.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -102.42 145.14 29.97 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.85 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.32 -30.35 25.61 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.909 -1.041 . . . . 0.0 113.207 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -116.4 -15.28 7.12 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 123.626 0.579 . . . . 0.0 113.328 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.1 t30 -95.73 -34.38 11.95 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.216 -0.993 . . . . 0.0 109.745 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -60.91 -38.31 85.32 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.28 15.65 2.85 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.788 -1.551 . . . . 0.0 112.538 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.3 m -115.27 -17.46 11.32 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -42.07 -55.58 6.15 Favored Pre-proline 0 N--CA 1.505 2.29 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.773 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 47.8 Cg_endo -56.8 -49.88 13.27 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 123.585 2.856 . . . . 0.0 112.074 176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -52.36 -44.65 65.36 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.546 -1.661 . . . . 0.0 111.845 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -49.69 12.05 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.6 m -75.22 -19.95 59.51 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.5 -1.28 . . . . 0.0 111.235 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 42.83 72.06 0.34 Allowed Glycine 0 N--CA 1.501 2.993 0 O-C-N 124.177 0.923 . . . . 0.0 113.442 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 76' ' ' SER . 17.6 t -104.84 -39.82 5.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 22.9 t 103.51 104.16 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 126.267 2.229 . . . . 0.0 106.938 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.27 166.32 14.78 Favored Pre-proline 0 N--CA 1.503 2.224 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.101 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.51 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 122.791 2.327 . . . . 0.0 111.958 167.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 1.2 p90 -135.0 169.75 16.95 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 110.444 -3.071 . . . . 0.0 112.544 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 81' ' ' ILE . 21.0 m -141.4 179.52 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.741 1.276 . . . . 0.0 110.141 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 81' ' ' ILE . 1.9 mp -75.93 82.7 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 1 N-CA-C 99.028 -4.434 . . . . 0.0 99.028 179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.419 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 35.8 t -108.12 173.2 6.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.843 -1.981 . . . . 0.0 108.357 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -9.0 21.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 113.338 -1.755 . . . . 0.0 106.319 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 85' ' ' ILE . 39.9 m -113.9 -52.17 2.75 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 117.85 -1.071 . . . . 0.0 111.621 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 1.6 tp -1.25 83.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.751 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -100.22 140.03 35.04 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.0 m -102.86 -173.01 2.22 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.388 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m 124.69 -39.48 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.88 0 C-N-CA 127.263 2.225 . . . . 0.0 108.09 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.0 52.16 0.73 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 HG21 ' SG ' ' A' ' 48' ' ' CYS . 61.0 t -121.67 73.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 112.203 -2.272 . . . . 0.0 107.924 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 116.835 -1.555 . . . . 0.0 111.543 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.5 m -129.03 152.08 49.03 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 124.033 0.833 . . . . 0.0 109.999 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 69.7 m -56.54 -42.17 78.03 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.93 -51.76 23.5 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -53.95 -50.42 66.52 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 113.747 -1.227 . . . . 0.0 108.013 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.0 t -54.68 -52.32 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.445 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -51.81 -46.92 64.44 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -62.12 -51.9 66.03 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.254 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -44.88 -51.87 9.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 123.71 0.632 . . . . 0.0 110.471 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -77.94 -19.93 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.649 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -31.63 -60.79 0.29 Allowed Glycine 0 N--CA 1.503 3.14 0 C-N-CA 123.126 0.394 . . . . 0.0 113.458 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.39 -43.34 54.89 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 124.364 3.376 . . . . 0.0 113.687 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.37 -32.64 70.4 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 122.952 0.501 . . . . 0.0 111.836 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.7 mt -43.4 -35.23 1.5 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 123.793 0.683 . . . . 0.0 112.189 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.1 p -53.21 -68.01 0.21 Allowed 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -54.75 -47.81 73.4 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 113.67 -1.605 . . . . 0.0 109.235 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -55.8 -32.81 63.86 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -74.9 -47.25 30.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.65 53.84 0.05 OUTLIER Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.85 -170.54 14.44 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.044 -2.422 . . . . 0.0 107.044 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.96 166.07 23.76 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.4 -166.33 13.73 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.768 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -67.52 166.64 64.11 Favored 'Cis proline' 0 N--CA 1.489 1.246 0 N-CA-C 108.921 -1.223 . . . . 0.0 108.921 -1.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.4 m -125.62 173.16 9.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.155 0.909 . . . . 0.0 111.282 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.98 -45.92 16.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.323 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.59 -48.47 81.54 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.336 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -58.83 -53.29 60.03 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.358 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 63.7 m -52.64 -58.81 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.218 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -47.01 -46.75 22.01 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.66 -54.34 38.06 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.8 t -52.58 -51.11 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.784 1.292 . . . . 0.0 108.425 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -48.22 -54.68 12.67 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.08 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 t -56.45 -48.47 77.0 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.811 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.7 tp -44.7 -60.5 1.98 Allowed 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -50.76 -61.02 2.46 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.123 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -40.38 -53.03 2.67 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 124.233 0.958 . . . . 0.0 111.937 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.05 -46.89 87.16 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.185 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.98 81.96 6.2 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.089 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.5 t -103.34 -46.48 4.58 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.288 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 99.4 m -79.64 152.02 30.23 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.818 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.6 m -35.35 -55.55 0.64 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.267 1.032 . . . . 0.0 112.426 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.0 -57.99 10.11 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 113.363 -1.744 . . . . 0.0 109.94 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.1 m-20 -52.95 -47.77 67.84 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.304 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' CD ' ' HA ' ' A' ' 91' ' ' SER . 43.5 ttm180 -52.55 -57.86 8.6 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 37.2 mtp180 -54.65 -48.44 72.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.3 m -50.14 -57.53 7.51 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.91 19.6 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 52.5 t -42.39 -58.1 2.34 Favored 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 122.254 1.026 . . . . 0.0 109.87 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 69.0 m-80 -57.28 -55.48 34.27 Favored 'General case' 0 N--CA 1.505 2.305 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 96.6 m -46.09 -46.49 16.97 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.27 -54.33 39.0 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -43.29 -50.14 6.66 Favored 'General case' 0 N--CA 1.509 2.514 0 CA-C-O 122.017 0.913 . . . . 0.0 109.751 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -60.61 -54.47 44.97 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.12 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -49.29 -44.06 43.77 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.223 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.53 39.31 0.53 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -103.65 -50.07 3.52 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.097 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.48 52.55 0.81 Allowed Glycine 0 N--CA 1.493 2.46 0 O-C-N 123.674 0.609 . . . . 0.0 113.74 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.2 mt -96.21 62.51 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -37.12 96.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.587 -1.188 . . . . 0.0 113.01 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.41 -24.21 3.96 Favored Glycine 0 N--CA 1.505 3.25 0 C-N-CA 121.448 -0.406 . . . . 0.0 112.101 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.1 tt -41.92 139.52 1.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.762 0.825 . . . . 0.0 111.753 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 65' ' ' ASN . 11.6 t-20 -95.31 161.55 14.04 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 124.187 0.929 . . . . 0.0 112.997 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.19 -44.38 15.1 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.76 26.48 9.41 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.166 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 62' ' ' ASN . 0.8 OUTLIER -133.17 -52.82 0.9 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -61.07 -41.26 96.3 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.58 13.62 3.62 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 112.684 -2.053 . . . . 0.0 113.055 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 78.0 p -114.97 -18.99 11.12 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.773 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.4 mm -36.64 -58.97 0.95 Allowed Pre-proline 0 N--CA 1.508 2.469 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 32.1 Cg_endo -51.71 -48.99 18.73 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 123.241 2.628 . . . . 0.0 110.822 -167.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -75.23 -49.11 20.38 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 111.435 -2.62 . . . . 0.0 110.168 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -43.23 -48.97 6.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 124.526 1.141 . . . . 0.0 110.159 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.9 t -82.66 -51.93 7.27 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 103.83 -2.655 . . . . 0.0 103.83 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.19 57.5 0.85 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 9.45 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p 31.24 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.59 156.71 51.1 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 91.3 Cg_endo -66.93 -48.85 1.68 Allowed 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 122.789 2.326 . . . . 0.0 112.305 172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 9.2 p90 -120.58 157.11 30.19 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.399 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.3 t -142.2 -149.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.7 mt -85.91 70.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.0 t -115.29 152.53 32.58 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.83 -10.4 18.26 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.9 t -128.62 66.33 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.2 tp -107.38 166.86 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.055 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -114.58 102.4 10.01 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 124.137 0.898 . . . . 0.0 111.704 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 15.5 m -110.73 66.13 0.62 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' C ' ' HD2' ' A' ' 89' ' ' ARG . 47.0 t -137.21 73.85 1.46 Allowed 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 88' ' ' SER . 2.8 mpt_? 63.76 75.97 0.37 Allowed 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -83.22 -33.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 112.414 -2.175 . . . . 0.0 112.563 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 44' ' ' ARG . 34.9 t . . . . . 0 N--CA 1.505 2.322 0 N-CA-C 117.269 2.322 . . . . 0.0 117.269 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 12.0 tt . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.2 p -134.64 161.27 35.59 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 96.9 m -58.16 -42.72 86.59 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.661 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -46.26 -53.55 9.29 Favored Glycine 0 N--CA 1.5 2.926 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -52.87 -51.42 61.15 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.45 -52.78 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.428 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -51.69 -48.53 63.45 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.0 m -61.59 -49.78 75.24 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.32 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.49 41.64 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 123.409 0.443 . . . . 0.0 109.816 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 m -79.07 31.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.338 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.93 -43.41 5.08 Favored Glycine 0 N--CA 1.496 2.636 0 CA-C-O 119.752 -0.471 . . . . 0.0 113.421 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 26.9 Cg_exo -68.07 -6.41 17.11 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.565 1.51 . . . . 0.0 112.896 161.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 97.3 m -106.56 -37.79 6.35 Favored 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 1.7 pt? -41.96 -37.69 1.4 Allowed 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.3 m -51.43 -59.85 3.79 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -59.56 -54.5 45.76 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.614 -1.63 . . . . 0.0 108.207 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 14' ' ' LEU . . . -39.4 -45.0 1.42 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.552 1.157 . . . . 0.0 113.567 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -83.11 -43.55 16.11 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.236 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.86 44.69 0.02 OUTLIER Glycine 0 N--CA 1.498 2.785 0 C-N-CA 118.914 -1.612 . . . . 0.0 112.672 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -119.47 -165.8 13.15 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 107.134 -2.387 . . . . 0.0 107.134 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.41 167.77 19.79 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.44 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.47 -164.78 17.74 Favored Glycine 0 N--CA 1.495 2.57 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.954 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.536 ' HB2' ' SG ' ' A' ' 73' ' ' CYS . 89.0 Cg_endo -66.73 150.64 81.4 Favored 'Cis proline' 0 C--N 1.313 -1.321 0 N-CA-C 108.688 -1.312 . . . . 0.0 108.688 -15.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.4 m -118.39 177.78 4.69 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -38.48 -56.24 1.3 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.536 1.148 . . . . 0.0 111.097 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.46 76.4 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.307 1.004 . . . . 0.0 112.991 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.407 ' SG ' HD12 ' A' ' 69' ' ' ILE . 10.0 t -64.27 -53.03 55.34 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.992 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 77.3 m -51.67 -54.3 29.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.1 t -48.0 -50.75 26.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -56.11 -51.15 57.56 Favored Glycine 0 N--CA 1.498 2.791 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.285 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.94 -47.02 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.3 mtt180 -54.0 -54.29 41.18 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.156 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -56.06 -43.65 78.12 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 tt -51.82 -62.86 1.37 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.75 -42.09 16.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -52.58 55.8 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.455 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.6 83.93 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.564 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -89.77 102.97 15.66 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.2 p -103.65 -64.57 1.08 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 116.28 1.955 . . . . 0.0 116.28 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.5 p -129.75 163.67 25.68 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 118.533 2.79 . . . . 0.0 118.533 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.0 m 19.45 -73.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 127.543 3.027 . . . . 0.0 116.608 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.3 -64.7 0.8 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.464 -1.698 . . . . 0.0 108.966 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.5 m-20 -52.45 -46.82 66.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.371 1.045 . . . . 0.0 108.667 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.509 ' HG2' ' CG1' ' A' ' 90' ' ' VAL . 17.3 ttm180 -54.56 -60.52 3.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.378 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -53.68 -50.05 66.67 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.3 m -49.62 -61.35 2.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.41 1.069 . . . . 0.0 108.147 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.81 -52.42 57.0 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.155 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 15.2 t -47.99 -57.04 6.29 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-N 119.766 1.166 . . . . 0.0 111.965 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.411 ' N ' ' SG ' ' A' ' 87' ' ' CYS . 71.1 m-80 -58.22 -47.28 83.98 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.312 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.0 m -51.79 -50.88 59.87 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 66.5 mt -57.27 -53.42 58.26 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -43.94 -60.74 1.71 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 124.2 0.937 . . . . 0.0 108.514 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -48.76 -56.8 7.6 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.974 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.98 -52.24 26.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.311 1.007 . . . . 0.0 110.345 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.66 -47.96 80.83 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.874 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -86.95 26.84 1.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.047 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -126.46 -46.68 0.21 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 84.4 mt -74.0 86.66 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 114.239 -0.98 . . . . 0.0 109.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -70.08 83.4 0.51 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 113.46 -1.7 . . . . 0.0 108.2 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.92 36.59 0.1 Allowed Glycine 0 N--CA 1.492 2.396 0 CA-C-N 113.248 -1.796 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.44 160.27 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -104.14 97.93 7.82 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.89 1.328 . . . . 0.0 110.184 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -45.74 -27.71 0.88 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 112.674 -2.057 . . . . 0.0 113.324 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.46 -34.36 3.13 Favored Glycine 0 N--CA 1.496 2.64 0 O-C-N 124.339 1.025 . . . . 0.0 113.873 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -85.38 -47.49 9.94 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.124 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -56.86 -50.09 73.49 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.95 -24.58 9.65 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 112.92 -1.945 . . . . 0.0 112.831 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.9 m -87.47 -10.89 50.6 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.1 mm -42.95 -57.96 4.47 Favored Pre-proline 0 N--CA 1.506 2.325 0 CA-C-N 118.594 0.634 . . . . 0.0 110.09 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 44.7 Cg_endo -56.27 -51.42 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 123.023 2.482 . . . . 0.0 111.423 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -52.23 -43.68 64.43 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 112.794 -2.003 . . . . 0.0 112.383 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.25 -49.99 10.1 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 23' ' ' PRO . 2.9 m -65.02 -55.55 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.084 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.48 52.78 0.9 Allowed Glycine 0 N--CA 1.494 2.565 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.266 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 t -114.64 60.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.3 t -34.29 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.142 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 m -113.28 155.19 44.89 Favored Pre-proline 0 N--CA 1.501 2.121 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.281 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -59.2 -43.37 42.15 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 123.759 2.973 . . . . 0.0 112.723 -176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 48' ' ' CYS . 4.7 p90 -126.87 156.92 40.63 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 111.187 -2.733 . . . . 0.0 108.52 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.6 t -132.28 -163.88 1.39 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.858 0.837 . . . . 0.0 111.239 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.97 69.98 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 100.672 -3.825 . . . . 0.0 100.672 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.521 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 23.1 t -99.13 164.79 12.01 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.13 -3.07 35.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.885 1.366 . . . . 0.0 107.34 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 96.1 p -114.93 -50.08 2.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 124.204 0.94 . . . . 0.0 110.561 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 82' ' ' SER . 4.0 tp -8.05 107.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.78 154.47 21.48 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 49' ' ' ASN . 10.6 m -105.07 61.71 0.69 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 125.631 2.634 . . . . 0.0 111.774 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.423 ' C ' ' HD2' ' A' ' 89' ' ' ARG . 14.4 p -121.13 -13.05 8.6 Favored 'General case' 0 C--N 1.289 -2.036 1 CA-C-N 108.208 -4.087 . . . . 0.0 110.285 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -120.79 45.09 2.32 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 101.818 -3.401 . . . . 0.0 101.818 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.509 ' CG1' ' HG2' ' A' ' 44' ' ' ARG . 59.5 t -126.69 85.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.152 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 117.372 -1.299 . . . . 0.0 107.757 179.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.499 2.013 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -131.72 159.16 39.21 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.555 0.693 . . . . 0.0 111.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.7 m -58.83 -35.25 72.6 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.707 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.13 -52.62 30.77 Favored Glycine 0 N--CA 1.501 3.014 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -55.67 -51.27 67.83 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.218 -0.991 . . . . 0.0 108.836 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.0 t -53.31 -52.77 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.022 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -52.18 -55.2 22.58 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 t -53.15 -37.66 62.05 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.686 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.04 -37.65 28.74 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.13 -24.77 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -27.19 -59.35 0.1 OUTLIER Glycine 0 N--CA 1.512 3.748 0 CA-C-N 118.334 0.515 . . . . 0.0 114.356 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -52.14 -41.83 62.82 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.733 2.955 . . . . 0.0 112.739 178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 85.8 m -73.4 -42.91 61.52 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.307 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -43.4 -41.82 4.38 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.4 m -51.11 -58.77 5.25 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -56.38 -57.44 12.25 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.076 -1.42 . . . . 0.0 108.634 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.9 -43.12 2.0 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.692 1.245 . . . . 0.0 112.993 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 61' ' ' LEU . 37.7 mtp180 -74.23 -52.06 13.52 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.737 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.48 55.08 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.947 -1.597 . . . . 0.0 110.35 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.59 -166.18 12.13 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.088 -2.005 . . . . 0.0 108.088 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -81.09 169.55 17.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.96 -176.28 18.11 Favored Glycine 0 N--CA 1.493 2.495 0 O-C-N 124.174 0.921 . . . . 0.0 111.545 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -71.19 156.23 96.57 Favored 'Cis proline' 0 N--CA 1.489 1.206 0 O-C-N 123.609 1.32 . . . . 0.0 108.717 -1.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 m -115.98 169.91 8.89 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -41.56 -52.3 3.75 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.828 1.33 . . . . 0.0 109.496 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.48 -50.86 68.79 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 125.277 1.611 . . . . 0.0 112.099 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.7 t -58.23 -53.64 55.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.08 -1.048 . . . . 0.0 108.542 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.9 m -53.69 -60.54 3.18 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.717 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 56.1 p -47.09 -44.93 21.62 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -54.8 34.49 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 120.266 -0.969 . . . . 0.0 110.681 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.1 t -55.9 -45.5 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -52.8 -52.34 57.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' ALA . 15.9 t -52.16 -54.82 26.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mp -44.51 -55.43 5.11 Favored 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -48.13 -52.2 21.58 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.171 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.27 -3.86 56.04 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 114.227 -1.351 . . . . 0.0 113.725 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' SER . . . -94.05 -40.79 9.89 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -91.71 144.6 25.35 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.1 t -121.53 -59.39 1.7 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 41' ' ' THR . 12.5 m -115.5 177.08 4.8 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.233 -179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.457 ' H ' HG22 ' A' ' 40' ' ' THR . 32.5 p -32.72 -51.88 0.3 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.969 -1.468 . . . . 0.0 113.831 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.57 -60.14 4.11 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.994 -0.682 . . . . 0.0 110.118 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 38.9 m-20 -50.64 -50.7 53.8 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.601 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -51.82 -55.11 21.85 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.169 -1.832 . . . . 0.0 110.715 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.505 ' CG ' ' N ' ' A' ' 46' ' ' THR . 0.3 OUTLIER -54.78 -50.91 67.34 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.505 ' N ' ' CG ' ' A' ' 45' ' ' ARG . 1.5 m -51.43 -60.09 3.52 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 125.328 1.643 . . . . 0.0 107.606 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.05 -59.33 4.0 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.582 0.628 . . . . 0.0 109.975 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 20.2 t -41.92 -59.82 1.59 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.175 0.988 . . . . 0.0 112.353 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -61.56 -50.31 73.16 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.176 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.7 m -45.78 -47.74 15.6 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.5 mt -63.85 -55.53 22.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -41.67 -48.49 4.14 Favored 'General case' 0 N--CA 1.507 2.42 0 CA-C-O 121.828 0.823 . . . . 0.0 110.962 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -67.52 -52.2 41.86 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.038 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.88 -46.09 42.1 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.81 0.338 . . . . 0.0 110.256 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.58 32.38 0.06 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.6 mtp-105 -111.0 -38.22 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.238 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.46 45.07 1.32 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 120.438 -0.887 . . . . 0.0 114.497 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.7 mt -116.45 58.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' H ' ' HD2' ' A' ' 59' ' ' LYS . 4.4 mptp? -6.05 -59.86 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 111.412 -2.631 . . . . 0.0 116.716 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.73 63.42 0.28 Allowed Glycine 0 N--CA 1.495 2.597 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.334 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 45.3 tp -87.39 164.76 16.04 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -106.16 154.07 21.21 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.766 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.41 -43.94 13.19 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 113.741 -1.572 . . . . 0.0 113.254 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.26 22.77 9.46 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.564 -0.827 . . . . 0.0 114.678 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -122.87 -44.76 2.18 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.62 -43.85 97.78 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.88 23.15 1.04 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.176 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.3 t -123.47 -23.88 4.71 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.113 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.496 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 7.1 mm -39.6 -55.4 3.46 Favored Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 33.5 Cg_endo -52.9 -50.22 14.83 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.824 2.349 . . . . 0.0 110.585 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -58.5 -47.66 83.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 125.979 2.05 . . . . 0.0 111.764 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.6 mmtp -63.97 -49.59 71.91 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.666 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 47.9 t -81.41 -49.95 10.04 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 117.243 -1.783 . . . . 0.0 106.434 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.85 48.02 0.92 Allowed Glycine 0 N--CA 1.497 2.722 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.03 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.31 58.6 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 102.144 -3.28 . . . . 0.0 102.144 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -31.87 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 113.219 -1.81 . . . . 0.0 115.2 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.2 m -111.6 157.88 38.04 Favored Pre-proline 0 N--CA 1.506 2.339 0 O-C-N 123.725 0.641 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.51 ' HG2' ' CE1' ' A' ' 79' ' ' TYR . 29.9 Cg_endo -80.46 5.25 6.21 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.365 2.043 . . . . 0.0 113.835 -175.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.51 ' CE1' ' HG2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -138.17 158.31 44.56 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 ' O ' ' C ' ' A' ' 81' ' ' ILE . 29.0 p -136.26 48.63 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.13 -1.428 . . . . 0.0 114.701 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.484 ' C ' ' O ' ' A' ' 80' ' ' THR . 69.9 mt 37.26 56.92 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.7 t -105.07 179.43 4.27 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.276 -1.784 . . . . 0.0 110.167 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.15 -12.0 19.12 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.778 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.1 p -97.66 -73.16 0.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.258 0.974 . . . . 0.0 110.581 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.5 tp 3.14 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 124.916 1.385 . . . . 0.0 114.286 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -93.98 63.99 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.578 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.4 m -30.64 128.27 0.14 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 112.923 -1.944 . . . . 0.0 113.2 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.6 m -172.92 -42.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 126.757 2.536 . . . . 0.0 108.009 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -122.66 75.47 1.27 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 111.998 -2.364 . . . . 0.0 108.831 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 98.9 t -106.94 -37.09 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 112.424 -2.171 . . . . 0.0 105.813 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 117.447 -1.263 . . . . 0.0 108.971 179.721 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.3 tt . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.3 p -131.97 164.07 26.97 Favored 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.759 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.5 m -55.32 -47.91 74.95 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.37 -50.05 30.43 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -54.94 -53.08 60.2 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -54.21 -53.06 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.702 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -51.47 -48.94 62.65 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 m -61.61 -52.44 64.38 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.874 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.45 -50.37 16.92 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 123.755 0.659 . . . . 0.0 112.163 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.17 -12.44 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -39.38 -58.29 2.07 Favored Glycine 0 N--CA 1.508 3.497 0 CA-C-N 119.739 1.154 . . . . 0.0 113.087 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' CYS . 12.7 Cg_exo -41.48 -29.62 0.76 Allowed 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 124.397 3.398 . . . . 0.0 115.597 174.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.05 -39.19 9.86 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.856 1.262 . . . . 0.0 109.794 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 64.3 tp -40.3 -44.46 1.93 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.509 -0.768 . . . . 0.0 112.792 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 81.1 m -51.61 -58.87 5.13 Favored 'General case' 0 N--CA 1.506 2.33 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -56.37 -48.19 77.35 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.268 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -63.51 -20.93 66.02 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.871 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -82.49 -47.14 12.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.85 49.98 0.06 OUTLIER Glycine 0 N--CA 1.493 2.496 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.45 -161.77 11.58 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 106.863 -2.495 . . . . 0.0 106.863 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.74 170.49 13.2 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.426 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.46 -168.75 17.49 Favored Glycine 0 N--CA 1.495 2.575 0 O-C-N 124.47 1.106 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' HB3' ' SG ' ' A' ' 27' ' ' CYS . 19.8 Cg_exo -73.67 162.48 91.98 Favored 'Cis proline' 0 C--N 1.315 -1.2 0 O-C-N 123.414 1.218 . . . . 0.0 109.996 -5.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p -125.32 174.72 7.95 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.183 -1.372 . . . . 0.0 111.352 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.49 -44.9 36.25 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.598 -1.637 . . . . 0.0 106.994 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.72 80.51 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.894 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 23' ' ' PRO . 6.4 t -55.08 -55.48 30.54 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' HH11 ' A' ' 32' ' ' ARG . 92.8 m -51.58 -60.22 3.39 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.6 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 t -44.79 -40.86 6.47 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 123.633 0.773 . . . . 0.0 109.795 179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.09 -54.28 28.52 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' LEU . 51.4 t -55.8 -41.23 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.479 HH12 HG22 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -56.49 -54.28 47.61 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.8 m -51.29 -47.13 62.65 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -47.2 -62.7 1.3 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HD3' ' CG1' ' A' ' 77' ' ' VAL . 24.2 mmmt -43.67 -57.29 3.27 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 124.427 1.08 . . . . 0.0 111.659 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.98 -57.66 10.17 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.198 -1.365 . . . . 0.0 114.305 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.43 88.84 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.833 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.69 47.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.5 t -34.2 -71.65 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 112.269 -2.241 . . . . 0.0 115.635 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.444 ' HA ' ' NH1' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -142.7 168.79 18.88 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -179.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 ' H ' HG22 ' A' ' 40' ' ' THR . 90.3 m 18.57 -74.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 126.833 2.583 . . . . 0.0 117.916 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.14 -58.01 4.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.903 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -54.42 -48.6 71.47 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 40' ' ' THR . 29.7 ttp180 -54.39 -60.19 3.67 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.849 -1.978 . . . . 0.0 111.553 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -53.24 -47.97 68.59 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 117.852 0.296 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.9 m -51.94 -58.83 5.35 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.14 -51.45 53.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 123.759 0.662 . . . . 0.0 110.121 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 49.4 t -45.54 -60.62 2.08 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.146 0.498 . . . . 0.0 110.957 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -56.49 -54.5 45.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.554 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.2 m -41.67 -54.81 3.15 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 124.193 0.933 . . . . 0.0 109.645 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.4 mt -59.49 -54.58 44.98 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.815 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -48.17 10.89 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.678 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -69.33 -49.54 54.76 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.056 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.76 -46.7 41.62 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.07 29.93 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 40.4 mtp-105 -114.92 -27.75 7.28 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.161 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.05 49.3 0.89 Allowed Glycine 0 N--CA 1.494 2.553 0 O-C-N 123.794 0.684 . . . . 0.0 114.38 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.1 mt -114.36 70.87 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -53.83 80.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 113.329 -1.76 . . . . 0.0 112.63 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.67 45.7 0.26 Allowed Glycine 0 N--CA 1.495 2.6 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.947 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 62' ' ' ASN . 22.3 tp -87.68 153.83 21.06 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 9.6 t-20 -101.64 90.38 4.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.15 -22.95 0.72 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.723 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -107.71 -22.14 7.49 Favored Glycine 0 N--CA 1.503 3.116 0 N-CA-C 116.01 1.164 . . . . 0.0 116.01 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -100.25 -33.04 10.58 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-N 118.038 0.919 . . . . 0.0 109.073 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -65.41 -38.5 90.13 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.07 24.86 0.62 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.548 -2.115 . . . . 0.0 109.753 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 66' ' ' ALA . 1.4 t -122.79 -21.71 5.52 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.858 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 8.3 mm -41.05 -55.83 4.57 Favored Pre-proline 0 N--CA 1.504 2.247 0 CA-C-O 118.538 -0.744 . . . . 0.0 112.372 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 36.3 Cg_endo -55.61 -51.76 9.11 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.369 2.046 . . . . 0.0 110.83 177.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.1 m -51.65 -41.51 61.39 Favored 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 111.534 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -77.27 -50.14 13.52 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.69 -63.2 1.38 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.9 59.86 0.58 Allowed Glycine 0 N--CA 1.502 3.036 0 CA-C-N 116.092 -0.504 . . . . 0.0 113.243 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.479 HG22 HH12 ' A' ' 32' ' ' ARG . 2.5 t -118.97 64.85 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.8 m -30.58 99.56 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 113.299 -1.773 . . . . 0.0 113.807 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.446 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -113.91 160.38 32.41 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 123.977 0.798 . . . . 0.0 110.154 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -103.14 36.3 0.05 OUTLIER 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 123.632 2.888 . . . . 0.0 110.483 -177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 15.1 p90 155.04 163.72 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.4 t -176.23 -150.66 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.5 mt -88.95 73.66 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 103.051 -2.944 . . . . 0.0 103.051 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 t -102.83 -159.52 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 112.281 -2.236 . . . . 0.0 106.828 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -64.96 1.0 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 46.8 t -125.09 63.87 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.5 tp -88.9 159.48 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.568 -1.651 . . . . 0.0 106.932 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -120.9 168.49 11.42 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.03 0.919 . . . . 0.0 111.662 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' SER . 63.7 m -145.69 163.98 33.22 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.349 -2.205 . . . . 0.0 106.674 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 41.2 t 108.45 -37.8 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.689 0 N-CA-C 104.945 -2.242 . . . . 0.0 104.945 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -95.28 37.17 1.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 34.3 t -121.74 55.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 122.407 1.099 . . . . 0.0 109.72 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 116.77 -1.586 . . . . 0.0 110.427 179.752 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.426 ' H ' ' NE2' ' A' ' 5' ' ' GLN . 69.0 p -132.55 162.1 32.12 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.3 m -62.45 -49.33 75.85 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -36.96 -54.98 1.45 Allowed Glycine 0 N--CA 1.502 3.07 0 O-C-N 124.244 0.965 . . . . 0.0 111.004 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' NE2' ' H ' ' A' ' 2' ' ' THR . 63.2 mt-30 -53.33 -56.8 13.72 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 114.585 -0.807 . . . . 0.0 109.628 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.4 t -54.14 -49.9 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.266 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -51.93 -51.28 58.08 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.4 t -58.56 -51.8 68.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 124.03 0.831 . . . . 0.0 109.781 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.47 59.59 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.0 m -78.02 28.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.72 -54.13 1.84 Allowed Glycine 0 N--CA 1.498 2.829 0 N-CA-C 107.985 -2.046 . . . . 0.0 107.985 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -44.71 -26.72 2.0 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 C-N-CA 122.853 2.368 . . . . 0.0 112.167 162.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.0 m -94.2 -39.17 10.69 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.024 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 59.5 tp -41.98 -50.64 4.57 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 16' ' ' TYR . 6.6 t -50.69 -53.79 28.35 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.411 ' N ' HG23 ' A' ' 15' ' ' THR . 88.2 t80 -55.54 -52.89 62.18 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ALA . . . -65.32 -15.45 62.55 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -87.79 -44.42 11.13 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.33 52.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.24 -165.26 11.77 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.374 -1.89 . . . . 0.0 108.374 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.0 169.44 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 122.42 -165.07 15.24 Favored Glycine 0 N--CA 1.497 2.708 0 O-C-N 124.31 1.006 . . . . 0.0 111.58 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -64.31 164.36 54.19 Favored 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.809 0.9 . . . . 0.0 109.845 -14.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.6 p -121.15 170.96 9.05 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.575 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.09 -33.69 2.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 124.902 1.376 . . . . 0.0 110.115 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -49.11 20.3 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.288 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.498 ' SG ' HD12 ' A' ' 69' ' ' ILE . 3.3 t -56.99 -48.9 77.32 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.7 m -54.46 -58.47 7.32 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 t -43.47 -41.8 4.53 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.31 -54.8 21.58 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 37.0 t -54.6 -41.76 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-O 122.767 1.27 . . . . 0.0 108.513 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -56.95 -56.76 17.56 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.3 m -47.55 -50.06 24.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 10.6 mp -49.86 -59.03 4.23 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 119.585 1.084 . . . . 0.0 108.282 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -45.24 -44.73 11.41 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.239 0.962 . . . . 0.0 112.037 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 -46.41 54.65 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 115.241 -0.891 . . . . 0.0 113.278 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.29 -43.51 83.23 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 124.305 1.042 . . . . 0.0 110.096 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -84.83 136.01 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.4 t -119.76 -49.56 2.33 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 41' ' ' THR . 57.5 m -124.5 179.32 4.99 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.613 1.197 . . . . 0.0 112.139 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.52 ' H ' HG22 ' A' ' 40' ' ' THR . 89.6 m -30.75 -54.73 0.2 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 112.24 -2.255 . . . . 0.0 113.605 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.21 -62.98 1.34 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.757 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.9 m-20 -53.52 -46.82 70.25 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.836 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.461 HH12 ' CB ' ' A' ' 91' ' ' SER . 12.8 ttt-85 -51.35 -57.34 9.17 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 124.371 1.044 . . . . 0.0 109.227 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -54.82 -49.92 69.84 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.5 m -49.45 -59.67 3.53 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.83 -57.17 9.09 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.481 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 11.4 t -37.57 -61.23 0.63 Allowed 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 122.573 1.177 . . . . 0.0 110.585 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -61.11 -53.31 58.66 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.185 -1.825 . . . . 0.0 111.22 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 68.7 m -46.16 -50.35 15.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 123.854 0.721 . . . . 0.0 109.669 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 60.6 mt -61.1 -55.65 30.1 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -44.32 -58.01 3.16 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 124.319 1.012 . . . . 0.0 109.177 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.63 -55.84 25.35 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.098 -1.41 . . . . 0.0 110.529 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -48.26 -51.45 25.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 123.795 0.684 . . . . 0.0 110.818 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.66 86.78 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -70.51 77.74 0.57 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.178 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.05 38.4 0.15 Allowed Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.051 -0.977 . . . . 0.0 115.394 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.4 mt -125.12 70.27 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt 0.76 -67.04 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 117.572 2.434 . . . . 0.0 117.572 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.42 60.96 0.33 Allowed Glycine 0 N--CA 1.499 2.893 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.833 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 28.1 tp -87.15 157.82 19.29 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -90.48 153.8 20.11 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.5 -36.47 20.51 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.261 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.18 -50.06 0.51 Allowed Glycine 0 N--CA 1.492 2.381 0 O-C-N 124.052 0.845 . . . . 0.0 111.597 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -51.75 -40.97 61.2 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.421 0.629 . . . . 0.0 109.747 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' ALA . . . -58.76 -43.29 90.27 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.37 19.18 1.59 Allowed 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 113.861 -1.518 . . . . 0.0 111.303 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 45.7 m -110.43 -14.0 14.18 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.334 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.498 HD12 ' SG ' ' A' ' 27' ' ' CYS . 10.8 mm -42.51 -55.08 7.34 Favored Pre-proline 0 N--CA 1.504 2.229 0 CA-C-O 118.461 -0.781 . . . . 0.0 111.568 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 31.2 Cg_endo -54.92 -50.46 13.18 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.911 2.407 . . . . 0.0 111.622 175.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -50.97 -43.84 60.52 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 113.72 -1.582 . . . . 0.0 110.993 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -75.86 -51.15 13.16 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 49.6 m -77.16 -62.51 1.63 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.487 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.91 54.57 0.63 Allowed Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.1 63.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 101.824 -3.398 . . . . 0.0 101.824 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 39.9 m -30.28 95.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 125.201 1.563 . . . . 0.0 113.554 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.85 150.18 38.37 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 123.977 0.798 . . . . 0.0 110.717 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 55.9 Cg_endo -71.38 -32.2 12.87 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 123.428 2.752 . . . . 0.0 112.314 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.481 ' CE2' ' HB2' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -112.63 160.05 18.26 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 81' ' ' ILE . 35.7 m -139.68 73.61 1.44 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 80' ' ' THR . 55.7 mt 29.71 56.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.795 0 CA-C-O 122.539 1.161 . . . . 0.0 108.219 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 40.1 t -113.19 154.35 26.84 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 113.311 -1.768 . . . . 0.0 114.468 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.24 2.15 31.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 112.464 -2.153 . . . . 0.0 108.212 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.5 t -110.76 -47.12 3.28 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.7 tp -25.42 137.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 O-C-N 125.333 1.646 . . . . 0.0 113.8 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -108.79 132.98 53.45 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.617 0.722 . . . . 0.0 110.728 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.5 m -131.21 171.42 13.33 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.441 -1.709 . . . . 0.0 108.251 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 82.5 p 123.68 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 102.592 -3.114 . . . . 0.0 102.592 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -125.29 69.45 1.15 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 103.205 -2.887 . . . . 0.0 103.205 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 91' ' ' SER . 5.3 p -88.33 -31.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 113.94 -1.482 . . . . 0.0 107.973 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.461 ' CB ' HH12 ' A' ' 44' ' ' ARG . 11.5 t . . . . . 0 N--CA 1.5 2.066 0 CA-C-O 114.985 -2.436 . . . . 0.0 106.702 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 63.6 m -126.28 149.43 49.12 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 123.818 0.699 . . . . 0.0 109.781 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 87.9 m -55.73 -45.88 77.87 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -48.49 -49.58 26.22 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 108.529 -1.829 . . . . 0.0 108.529 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -55.16 -54.72 39.7 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -53.88 -51.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.209 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -52.33 -52.75 51.47 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.5 m -55.55 -50.16 70.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.292 0.995 . . . . 0.0 109.756 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.59 -57.17 9.88 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 123.475 0.484 . . . . 0.0 109.978 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 m -81.88 34.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.172 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.47 -55.22 1.71 Allowed Glycine 0 N--CA 1.501 2.991 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -44.0 -23.95 0.76 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.402 2.735 . . . . 0.0 112.171 162.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.3 m -96.41 -41.47 8.59 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.485 -1.234 . . . . 0.0 109.423 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 tt -43.24 -47.22 6.42 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 17.4 p -50.72 -51.9 45.43 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -61.41 -55.75 27.95 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.362 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.88 -32.94 6.83 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.583 0.706 . . . . 0.0 112.263 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -74.9 -50.71 15.97 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.633 -1.621 . . . . 0.0 107.522 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.62 62.78 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.734 -1.747 . . . . 0.0 108.734 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.44 178.83 17.91 Favored Glycine 0 N--CA 1.497 2.737 0 CA-C-N 113.895 -1.152 . . . . 0.0 110.458 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.73 68.74 6.5 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.562 1.172 . . . . 0.0 109.714 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.56 -167.44 13.39 Favored Glycine 0 N--CA 1.487 2.078 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.279 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD3' ' NZ ' ' A' ' 72' ' ' LYS . 5.5 Cg_exo -83.35 177.26 31.48 Favored 'Cis proline' 0 C--N 1.315 -1.206 0 O-C-N 122.742 0.864 . . . . 0.0 110.227 -4.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.5 p -129.69 166.74 19.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.844 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.12 65.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -53.11 61.99 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.602 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 69' ' ' ILE . 4.4 t -54.85 -52.13 63.75 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.645 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HB3' ' NH1' ' A' ' 32' ' ' ARG . 6.1 m -51.97 -56.14 16.02 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 t -53.41 -30.63 41.16 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.4 -54.17 21.33 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 105.465 -3.054 . . . . 0.0 105.465 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.5 -48.85 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH1' ' HB3' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -48.58 -55.79 10.17 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -51.42 -48.03 62.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 tp -49.49 -58.42 5.21 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 76' ' ' SER . 27.0 mmmt -43.87 -55.54 4.48 Favored 'General case' 0 N--CA 1.507 2.38 0 CA-C-N 113.423 -1.717 . . . . 0.0 109.87 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.58 -52.18 65.79 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.092 -1.413 . . . . 0.0 113.409 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.41 -44.49 92.82 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.415 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -88.56 104.68 17.05 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.5 t -106.02 -53.05 2.7 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.8 p -114.02 178.43 4.28 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.66 0.743 . . . . 0.0 112.74 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.0 p -32.27 -60.83 0.27 Allowed 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 113.542 -1.663 . . . . 0.0 115.283 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.74 -58.04 9.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 123.833 0.708 . . . . 0.0 112.705 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 6.1 m-20 -53.06 -50.59 64.02 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 123.575 0.547 . . . . 0.0 110.245 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 34.1 ttp180 -54.96 -57.37 11.94 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.082 -1.417 . . . . 0.0 109.791 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 56.9 mtt180 -53.63 -50.4 65.8 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.703 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -50.56 -59.97 3.5 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.21 -51.95 55.19 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 118.404 0.547 . . . . 0.0 109.555 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 t -44.9 -58.39 3.17 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 121.999 0.904 . . . . 0.0 110.314 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 45' ' ' ARG . 71.6 m-80 -58.84 -54.04 51.57 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.157 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.2 m -43.07 -51.6 5.73 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 67.4 mt -60.85 -55.06 37.58 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -43.34 -54.84 4.41 Favored 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 122.057 0.932 . . . . 0.0 109.79 179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -53.91 -60.56 3.17 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.405 -1.725 . . . . 0.0 110.58 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 58' ' ' ILE . . . -48.96 -51.47 30.21 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.54 -56.32 21.7 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 124.971 1.42 . . . . 0.0 110.997 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -35.86 -41.09 0.21 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.448 1.093 . . . . 0.0 113.144 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -106.78 33.14 6.64 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 117.626 1.81 . . . . 0.0 117.626 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ALA . 36.8 mt -103.98 67.19 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -12.18 -55.92 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 112.381 -2.19 . . . . 0.0 116.522 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.84 63.27 0.32 Allowed Glycine 0 N--CA 1.497 2.749 0 O-C-N 123.84 0.713 . . . . 0.0 111.991 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 tp -87.06 166.31 15.13 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -103.31 150.82 23.4 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.822 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.4 -41.02 17.11 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.871 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -119.92 26.83 7.01 Favored Glycine 0 N--CA 1.5 2.953 0 C-N-CA 120.735 -0.745 . . . . 0.0 114.145 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -123.15 -45.04 2.13 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.08 89.77 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.34 20.45 2.0 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.104 -1.862 . . . . 0.0 110.746 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.5 t -113.82 -37.74 4.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 HD12 ' SG ' ' A' ' 27' ' ' CYS . 18.6 mm -37.87 -59.74 1.09 Allowed Pre-proline 0 N--CA 1.504 2.267 0 CA-C-O 118.389 -0.815 . . . . 0.0 111.173 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.419 ' CD ' ' HB ' ' A' ' 69' ' ' ILE . 39.0 Cg_endo -56.58 -52.38 7.11 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.028 1.818 . . . . 0.0 111.667 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 t -50.81 -41.22 57.18 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.989 -1.914 . . . . 0.0 114.031 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.407 ' NZ ' ' HD3' ' A' ' 23' ' ' PRO . 19.6 ptmt -97.41 -32.32 11.91 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.94 -57.14 3.22 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 103.612 -2.736 . . . . 0.0 103.612 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.55 73.1 1.26 Allowed Glycine 0 N--CA 1.503 3.146 0 C-N-CA 120.785 -0.721 . . . . 0.0 113.364 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.01 33.32 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.156 0.979 . . . . 0.0 109.747 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 71.3 p 29.18 69.0 0.08 Allowed 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 118.944 2.942 . . . . 0.0 118.944 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.3 m -102.93 152.67 38.53 Favored Pre-proline 0 N--CA 1.509 2.477 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.49 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -97.99 32.61 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 123.271 2.647 . . . . 0.0 110.75 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 11.3 p90 156.04 155.45 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 125.5 1.75 . . . . 0.0 107.431 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.2 t -144.28 -148.14 0.23 Allowed 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 92.6 mt -90.18 71.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 101.526 -3.509 . . . . 0.0 101.526 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -114.46 156.01 25.33 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.248 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.23 -7.45 20.07 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.791 -2.004 . . . . 0.0 108.388 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.1 p -117.35 42.91 2.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.679 0.752 . . . . 0.0 111.149 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.1 tp -120.89 143.0 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -126.4 67.83 1.22 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.448 ' O ' ' CB ' ' A' ' 88' ' ' SER . 35.5 m -44.02 144.12 0.99 Allowed 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 87' ' ' CYS . 34.4 t 128.37 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 N-CA-C 101.706 -3.442 . . . . 0.0 101.706 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -92.09 50.27 1.63 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.46 60.58 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-N 112.384 -2.189 . . . . 0.0 108.945 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 14.7 tt . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.9 p -130.66 160.28 34.73 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.446 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.5 m -58.15 -45.62 87.1 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.331 -0.947 . . . . 0.0 108.592 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -42.38 -53.96 4.84 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.69 -52.79 58.91 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.07 -1.065 . . . . 0.0 108.872 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.1 t -54.78 -49.63 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -52.36 -53.26 47.04 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -54.6 -51.24 65.94 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.314 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.46 -51.09 38.04 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.721 0.638 . . . . 0.0 111.686 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 m -76.1 -22.93 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 113.966 1.098 . . . . 0.0 113.966 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -26.24 -58.49 0.08 OUTLIER Glycine 0 N--CA 1.509 3.505 0 N-CA-C 114.896 0.718 . . . . 0.0 114.896 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.97 -37.04 68.08 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 124.517 3.478 . . . . 0.0 114.694 177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 70.7 m -74.33 -33.33 63.12 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.557 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 tp -40.27 -46.63 2.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.221 -1.354 . . . . 0.0 114.343 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.7 m -52.57 -55.96 18.59 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -59.65 -51.79 68.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.326 -1.307 . . . . 0.0 109.092 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.87 -24.55 52.52 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.461 HH11 ' C ' ' A' ' 58' ' ' ILE . 7.7 tpt180 -78.83 -51.58 9.53 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.8 51.31 0.04 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.65 -158.44 10.05 Favored Glycine 0 N--CA 1.49 2.252 0 CA-C-N 112.597 -1.802 . . . . 0.0 108.715 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.95 170.35 12.4 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.478 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.16 -171.04 17.1 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -76.18 168.03 78.43 Favored 'Cis proline' 0 C--N 1.315 -1.194 0 N-CA-C 109.299 -1.077 . . . . 0.0 109.299 -2.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -124.17 172.85 8.72 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.863 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.04 -45.95 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.79 -54.51 45.56 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.005 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.1 t -52.28 -55.73 19.46 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.676 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.2 m -47.45 -59.19 3.4 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.227 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.0 t -43.76 -50.26 7.77 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.8 -49.49 77.95 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 120.057 -1.068 . . . . 0.0 111.639 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.0 t -57.79 -49.04 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 CA-C-N 118.843 1.322 . . . . 0.0 108.31 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -49.19 -56.44 9.25 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 113.496 -1.683 . . . . 0.0 108.37 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.4 p -61.75 -42.69 99.31 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.114 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tt -47.44 -61.8 1.74 Allowed 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -63.91 -40.67 97.04 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.394 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' N ' ' HD3' ' A' ' 35' ' ' LYS . . . -52.59 -51.15 61.23 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.75 -45.75 91.25 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 43' ' ' ASP . . . -79.64 73.21 6.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.7 t -92.5 -52.96 4.4 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 50.1 m -93.84 157.88 15.92 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.848 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.1 p -35.58 -53.96 0.69 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.22 35.13 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 27.6 m-20 -52.86 -52.66 56.45 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.461 0.648 . . . . 0.0 110.42 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -51.26 -56.02 15.14 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.504 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 -55.82 -48.36 75.56 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.8 m -50.57 -58.36 5.98 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.01 -54.87 20.76 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 51.3 t -44.52 -58.44 2.99 Favored 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.177 0.513 . . . . 0.0 110.827 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -59.73 -51.87 67.92 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.103 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.6 m -44.44 -52.03 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.94 -52.89 62.22 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -42.54 -44.32 4.09 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.469 1.106 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -74.99 -54.94 6.3 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 56' ' ' ARG . . . -47.13 -48.51 23.12 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.586 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.61 12.16 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 115.68 1.734 . . . . 0.0 115.68 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 54' ' ' ALA . 54.1 mtt-85 -114.28 -10.32 12.72 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.042 0.137 . . . . 0.0 111.131 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.22 29.28 7.44 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' C ' HH11 ' A' ' 18' ' ' ARG . 56.9 mt -120.42 63.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -5.94 -63.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 117.451 2.389 . . . . 0.0 117.451 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -112.77 67.71 0.24 Allowed Glycine 0 N--CA 1.497 2.732 0 O-C-N 123.626 0.578 . . . . 0.0 111.863 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.4 tp -85.21 159.9 20.0 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -103.28 98.68 8.56 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.079 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.03 -27.15 2.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 124.151 0.907 . . . . 0.0 112.783 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.8 -13.48 16.15 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -103.23 -31.83 9.91 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 118.639 1.22 . . . . 0.0 108.642 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.21 -28.66 66.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.27 12.06 7.28 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.554 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.1 t -115.43 -32.01 5.73 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 117.724 -1.132 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.469 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 17.0 mm -38.34 -60.21 1.09 Allowed Pre-proline 0 N--CA 1.509 2.503 0 CA-C-N 118.636 0.653 . . . . 0.0 112.368 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 69' ' ' ILE . 52.4 Cg_endo -56.51 -54.1 4.32 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 122.424 2.083 . . . . 0.0 110.437 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.444 ' H ' ' HG2' ' A' ' 70' ' ' PRO . 33.6 t -55.06 -49.19 72.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 126.071 2.107 . . . . 0.0 111.479 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -64.21 -50.64 67.26 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 t -64.89 -45.49 85.71 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 116.667 -2.013 . . . . 0.0 107.207 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.68 44.64 1.51 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 6.3 t -116.74 56.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 101.281 -3.6 . . . . 0.0 101.281 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.4 p -33.15 83.63 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 112.846 -1.979 . . . . 0.0 115.239 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.68 146.12 33.38 Favored Pre-proline 0 N--CA 1.501 2.099 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.287 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.529 ' HG2' ' CD2' ' A' ' 79' ' ' TYR . 58.4 Cg_endo -57.32 -42.2 64.85 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.719 2.946 . . . . 0.0 114.539 -174.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' CD2' ' HG2' ' A' ' 78' ' ' PRO . 32.0 p90 -123.89 160.24 27.92 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 112.058 -2.337 . . . . 0.0 109.462 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.4 t -144.43 -154.18 0.52 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 55.4 mt -80.49 74.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.0 t -115.61 149.2 38.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.31 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 -4.44 25.13 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.394 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.6 t -125.77 44.17 2.9 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.2 tp -116.52 157.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' O ' ' SG ' ' A' ' 87' ' ' CYS . 55.0 t0 -127.09 -48.75 1.46 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 86' ' ' ASP . 77.0 m 120.56 155.1 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 100.526 -3.879 . . . . 0.0 100.526 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.1 m -147.04 78.19 1.48 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.534 -0.866 . . . . 0.0 109.483 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.6 mtt-85 56.55 64.84 1.56 Allowed 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.519 1.152 . . . . 0.0 108.033 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 5.7 t -89.44 64.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 113.074 -1.876 . . . . 0.0 107.037 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 76.0 p . . . . . 0 N--CA 1.496 1.864 0 CA-C-N 113.287 -1.779 . . . . 0.0 109.933 179.858 . . . . . . . . 0 0 . 1 stop_ save_